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PREFACE 
 
This thesis is based on three studies carried out during my positions at the 
Department of Cardiology, North Denmark Regional Hospital, Hjørring, and the 
Department of Clinical Medicine, Aalborg University. It has been an unpredictable 
journey, which took me from my comfort zone in echocardiography and left me in 
the middle of a challenging field of cardiovascular epidemiology, surrounded by 
many inspiring, talented, and dedicated colleagues whom I look forward to working 
with in the years to come. 
 
I want to express my sincere gratitude to all those who have helped me directly or 
indirectly during the past years, keeping in mind that those things for which we are 
most grateful could be the most difficult to put down in words. 
 
First, I want to thank everyone at my workplace at Hjørring Hospital. Thanks to 
Gitte Nielsen for believing in me and my research skills, for encouraging me and for 
thinking with the heart. My wonderful colleagues Asta Blaskauskaite, Jens 
Petersen, Holger Sejersen, Adam Plocharski, Marek Zelechowski, and Peter Stæhr 
admired my research and I am grateful for their support and understanding during 
the periods of my absence from clinical work. Special thanks to Asta for being 
caring, helpful and for making me feel like a star. The days I spent in clinical work 
were especially enlightened by Christina Skov and her staff, and I want to thank 
Christina for her easy-going personality, her managing skills and for her thoughtful 
support of me. Gitte and Christina remain for me a source of inspiration for how to 
create a pleasant workplace. 
 
In Hjørring, I also had the pleasure of meeting Professor Ulrik Baandrup, whom I 
met for the first time many years ago at Aarhus University when I was a medical 
student. His passion and enthusiasm for his profession and research is true 
inspiration for many young researchers.  
 
I want to thank everyone I met at the Centre for Clinical Research. Special thanks to 
Suzette Sørensen, Dorthe Brønnum, and Dorte Melgaard for interesting 
discussions, and to Lise Kristiansen for help with finding articles.  
 
I would like to thank my former clinical supervisor Ole Eschen for inspiring me to 
work with cardiovascular research and for convincing me to join the Copenhagen 
City Heart Study. Thanks to Peter Søgaard for introducing me to clinical research in 
cardiac imaging. His dedication to echocardiography, research and his many ideas 
are inspiring. I also want to thank Peter for introducing me to the Copenhagen City 
 Population study of Physical Activity  
10 
 
Heart Study by introducing me to Jan Skov Jensen. I am grateful to Jan for including 
me and for his quick, constructive, and critical feedback on my work.  
 
Rasmus Møgelvang stood beside me from the beginning to the end of this PhD. I 
want to thank Rasmus for his guidance, accountability, commitment, and for 
finding time to address my concerns properly in a very busy schedule. I am 
especially grateful for his scientific enthusiasm and active presence in every stage 
of the process, from discussing the ideas until the publication of the articles. 
Working with Rasmus gave me determination, ambitions, and a faith that I will be 
able to achieve my professional goals.  
 
Jacob Louis Marott was the main reason I became fascinated by both epidemiologic 
research and the Copenhagen City Heart Study. His knowledge of statistics and 
epidemiology is tremendous. I want to thank Jacob for improving the scientific 
quality of my studies, for making my scientific victories grander and the difficult 
days easier to overcome. His loyalty to the Copenhagen City Heart Study, his 
passion and dedication for research is contagious and admirable. Above all, Jacob is 
a truly kind and empathetic person caring for the people surrounding him.  
 
I would like to thank the staff at the Copenhagen City Heart Study, Frederiksberg 
Hospital, where I was met with nothing but kindness, a place where I always found 
the doors open. I especially want to thank Gorm Boje Jensen, Peter Schnohr, 
Merete Appleyard, Anne-Birgitte Hjuler Ammari, and Anja Lykke Madsen for having 
me and helping me through the past years.  
 
Thanks to Tor Biering-Sørensen and Eva Prescott for their help in my studies, 
especially for the constructive discussion of ideas and reviews of the methodology. 
It has been a pleasure to discuss my studies with Christian Torp-Pedersen, who 
contributed with immense knowledge and critical feedback. Further, I want to 
thank Ann-Eva Christensen and Martin Nygård Johansen for their statistical advice.  
 
I was part of the motivating and well-organised research environment at the 
Department of Cardiology, Rigshospitalet, during the final year of my PhD-studies. I 
want to thank everyone I met here, especially the PhD-students for including me 
and for their friendliness. Special thanks to my colleagues from ‘TeamSkrald’ for 
creating a lovely atmosphere: Johannes Grand, Jakob Josiassen, Frederik Grund, 
Christoffer Vissing, Divan Topal, Katrine Myhr, and Marie Elming.  
 
Thanks to Niels Holmark Andersen for his unbiased collegial and moral support, for 
being a continuous inspiration for me in cardiology, and for proving how to keep 
your feet on the ground when reaching for the stars. 
 
Last, but not least, I want to thank my wonderful colleague and friend Majbritt 
Tang Svendsen for always being a step ahead of me, for being my greatest 
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cheerleader, and for painting me beautiful sunny pictures when the lines in my 
drawings seemed like blurred clouds.  
 
 
 
Gowsini Joseph, 
Copenhagen,  
December 2019 
  
 Population study of Physical Activity  
13 
 
PAPERS INCLUDED IN THE PHD-THESIS 
 
This PhD-thesis is based on the following three papers. 
 
Publication II is selected as High Impact Paper by American Heart Association and 
Hypertension, Winter Collection 2019. 
 
Publication II and III are currently in the top 5% of all research outputs scored by 
Altmetric (July 2020).  
 
 
I The association between physical activity and cardiac performance is 
dependent on age: the Copenhagen City Heart Study. 
 
Joseph G, Mogelvang R, Biering-Sørensen T, Nielsen G, Schnohr P, 
Sogaard P. 
Int J Cardiovasc Imaging. 2019;35(7):1249-1258.  
doi:10.1007/s10554-019-01566-0 
 
 
 
II Dose-Response Association Between Level of Physical Activity and 
Mortality in Normal, Elevated, and High Blood Pressure  
 
Joseph G., Marott J.L., Torp-Pedersen C., Biering-Sørensen T., Nielsen G., 
Christensen A., Johansen M.B., Schnohr P., Sogaard P., Mogelvang R.   
Hypertension. 2019;74(6):1307-1315. 
doi:10.1161/HYPERTENSIONAHA.119.13786 
 
 
 
III Level of Physical Activity, Left Ventricular Mass, Hypertension, and 
Prognosis 
 
Joseph G., Marott J.L., Biering-Sørensen T., Johansen M.N., Sævereid 
H.A., Nielsen G., Schnohr P., Prescott E., Sogaard P., Mogelvang R. 
Hypertension. 2020;75(3):693-701. 
doi:10.1161/hypertensionaha.119.14287 
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ABBREVIATIONS 
AMI: acute myocardial infarction 
BMI: body mass index 
BP: blood pressure 
CI: confidence intervals 
CPR: Civil Personal Register 
CRS: Civil Registration System 
CVD: cardiovascular disease 
EF: ejection fraction 
ET: ejection time 
ICD: International Classification of Diseases 
IVCT: isovolumetric contraction time 
IVRT: isovolumetric relaxation time 
LD: longitudinal displacement 
LV: left ventricle 
LVEF: left ventricular ejection fraction 
LVH: left ventricular hypertrophy 
LVM: left ventricular mass 
LVMi: left ventricular mass index 
METs: metabolic equivalents 
MPI: myocardial performance index 
TDI: tissue Doppler imaging 
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ENGLISH SUMMARY 
Physical inactivity is one of the major causes of global death. Physical activity is 
associated with reduction of cardiovascular and respiratory diseases as well as 
malignant diseases and is considered an anti-depressive treatment. The World 
Health Organisation (WHO) recommends regular physical activity of a moderate 
amount to improve and maintain health. 
 
Another threat to global health is the growing prevalence of hypertension.   
The WHO has declared hypertension to be the leading cause of death worldwide. 
The prevalence of hypertension is increasing, both in Western countries and in 
developing countries, advancing it to a major public health problem. Public health 
interventions with low economic cost are needed.  
 
This thesis includes studies in the fields of physical activity, cardiac function, and 
hypertension. In the first study, we describe how the association between the level 
of physical activity and cardiac function is dependent on age. This raises several 
questions. Is an ageing heart capable of adapting the physiological changes induced 
by physical activity? Should recommendations regarding physical activity be 
classified according to age? Is physical activity dangerous in the elderly? 
 
The second study describes how the association between physical activity and 
reduction in mortality has a dose-response pattern at all levels of blood pressure 
(BP) (normal BP, pre-hypertension, stage 1 hypertension, stage 2 hypertension). 
The reduction in cardiovascular events was independent of the level of physical 
activity. The most important message is that most of the health benefits are 
already achieved at a light level of physical activity, which is a level almost 
everyone can achieve. Previously, many physicians had precautions in 
recommending physical activity for persons in stage 2 hypertension. It is important 
to underscore that our main results were persistent for persons in stage 2 
hypertension (≥ 160/100 mmHg) as well as the subgroup of patients with BP 
>180/110 mmHg. The current ESC-guidelines do not recommend physical activity in 
BP>180/110 mmHg.  
 
The third study explores the impact of physical activity in a high-risk population: 
hypertensive patients with left ventricular hypertrophy (LVH). Patients with 
hypertension had significantly higher left ventricular mass (LVM) compared with 
persons with normal BP. Higher levels of physical activity were associated with a 
higher LVM in normal BP, whereas this association was not present in persons with 
hypertension. After a mean follow-up of 12 years, we found that higher levels of 
physical activity were associated with a reduction in all-cause mortality and 
especially cardiovascular endpoints independent of whether LVH was present.  
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Besides raising important questions on the association between physical activity 
and cardiac performance, this thesis provides new scientific knowledge on the 
importance of physical activity in the treatment of hypertension including the 
subgroups of high-risk hypertensive patients. 
  
 Population study of Physical Activity  
19 
 
DANSK RESUMÉ  
Fysisk inaktivitet er en af de vigtigste årsager til død på globalt plan. Fysisk aktivitet 
er ikke blot forbundet med mindre risiko for udvikling af hjerte-karsygdomme, men 
også forbundet med nedsat risiko for visse kræftsygdomme, lungesygdomme og 
vist at være gavnlig i behandling af depression.  
Verdenssundhedsorganisationen WHO anbefaler regelmæssig fysisk aktivitet af 
moderat grad for at forbedre og opretholde et godt helbred.  
Et andet globalt omspændende sundhedsproblem er den stigende forekomst af 
hypertension (forhøjet blodtryk). WHO har erklæret hypertension som værende 
den største risikofaktor for dødelighed verden over. Antallet af personer, der 
udvikler hypertension, er fortsat stærkt stigende, såvel i de vestlige lande som i 
udviklingslandene. Dette rejser et stort behov for behandlingstiltag med lave 
økonomiske omkostninger. 
Aktuelle PhD-afhandling indeholder 3 studier, der undersøger sammenhæng 
mellem fysisk aktivitet, hjertefunktion og forhøjet blodtryk. Det første studie 
beskriver, hvorledes sammenhængen mellem graden af fysisk aktivitet og 
hjertefunktion er afhængig af alder. Dette studie giver anledning til flere spørgsmål, 
herunder om det aldrende hjerte er mindre i stand til at tilpasse fysiologiske 
ændringer forårsaget af fysisk aktivitet. Herudover, om anbefalingerne for fysisk 
aktivitet bør tilpasses aldersgruppe, og om fysisk aktivitet rent faktisk kan være 
farligt for den ældre befolkningsgruppe. 
Andet studie i afhandlingen redegør for, hvordan stigende niveau af fysisk aktivitet 
er forbundet med tilsvarende reduktion i dødelighed og hjertekarsygdomme ved 
alle niveauer af blodtryk (normalt blodtryk, præ-hypertension, stadie 1 
hypertension og stadie 2 hypertension). Det vigtigste budskab er, at den største del 
af helbredsgevinsten er opnået allerede ved let grad af fysisk aktivitet, som er et 
niveau, som langt de fleste personer er i stand til at opnå. Vores resultater gælder 
også for stadie 2 hypertension (blodtryk ≥ 160/100 mmHg), hvor læger tidligere har 
været tilbageholdende med at anbefale fysisk aktivitet, samt hos undergruppen af 
personer med blodtryk >180/110 mmHg, hvor der i aktuelt gældende europæiske 
retningslinjer ikke anbefales fysisk aktivitet.  
Det tredje studie belyser fordelene ved fysisk aktivitet i en høj-risiko population, 
nemlig patienter med hypertension, der også har et tykt hjerte (venstre 
ventrikelhypertrofi). Venstre ventrikelhypertrofi er forbundet med stærk 
forværring af prognose hos patienter med forhøjet blodtryk. Patienter med 
forhøjet blodtryk havde ved baseline højere niveau af venstre ventrikeltykkelse ift. 
personer med normalt blodtryk. Stigende niveau af fysisk aktivitet var forbundet 
med højere venstre ventrikeltykkelse hos personer med normalt blodtryk, medens 
dette ikke gjaldt personer med forhøjet blodtryk. Efter mere end 12 års opfølgning 
kunne vi påvise, at højere niveau af fysisk aktivitet var forbundet med reduktion i 
død, og især en betydelig reduktion i forekomsten hjertekarsygdomme. Dette 
gjaldt også højrisikogruppen af personer med venstre ventrikelhypertrofi. 
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Udover at stille spørgsmålstegn ved sammenhæng graden af fysisk aktivitet og 
hjertefunktion, skaber aktuelle afhandling også ny viden om vigtigheden af fysisk 
aktivitets betydning for behandling af patienter med forhøjet blodtryk, herunder 
høj-risiko gruppen i denne patientkategori.  
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INTRODUCTION 
 
‘People here say there’s no such thing as bad weather. Only bad clothing’. 
Recently, the New York Times again published an article about the famous bicycling 
culture in Copenhagen, something Denmark is admired for internationally 
alongside its high status in the World Happiness Report 1. However, according to 
the Danish National Health Profile, 28.8% of the Danish population does not fulfil 
the WHO recommendations for physical activity (2017: 28.2% of men and 29.4% of 
women) 2. For adults 18-64 years, WHO recommends a minimum of 150 minutes 
physical activity of moderate intensity or 75 minutes of activity at a high intensity 
per week 3.  
These recommendations are based on a large number of observational and 
experimental studies describing and verifying the health benefits of physical 
activity both in healthy individuals and in persons with known heart disease 4–13. 
The landmark study made by Morris et al. in the 1950s introduced us to the 
cardiovascular benefits of regular physical activity: Active bus conductors and 
postmen had a 50% lower event rate from coronary heart disease compared with 
less active bus drivers and clerical workers in the post offices 14. Since then, many 
other studies have confirmed these findings 15,16.  
Physical activity promotes longevity, improves physical and mental well-being, 
reduces the risk of some malignancies, delays the onset of dementia and reduces 
the risk of depression 17–20. In the cardiovascular field, we already know that regular 
physical activity reduces BP 21, improves the lipid profile 22, and increases insulin 
sensitivity 23,24. In recent years, exercise has also been established as a cornerstone 
in cardiac rehabilitation 25. 
Intense physical activity, such as marathon runs, has attracted much attention in 
modern time. Recent studies have questioned whether competitive physical 
activity might induce damage to the heart and worsen the prognosis 26–28.  
Thus, exercise and physical activity remain a continuous issue in the scientific 
debate since the health benefits seem to be enormous and widespread, while 
intense levels of physical activity might be associated with cardiac alterations that 
might be harmful. Further studies are needed to clarify the role of physical activity 
in cardiovascular disease and the impact on the general population. 
Besides physical inactivity, a major threat to global health is the growing 
prevalence of hypertension.   
WHO has declared hypertension to be the leading cause of death worldwide 29. The 
higher frequency of hypertension is found in Western countries as well as in the 
developing countries, advancing it to a major global public health problem 30. Public 
health interventions with low economic cost are needed.  
 
In the three studies included in this thesis, we studied physical activity in the 
general Danish population in terms of cardiac function assessed by tissue Doppler 
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echocardiography, association with cardiac morphology, and the importance of 
physical activity on the prognosis in hypertension. The purpose of these studies 
was to acquire new knowledge of the association between physical activity, cardiac 
function, and the health benefits of physical activity in hypertensive persons.  
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OBJECTIVES 
Study I 
Since many previous observational studies have implied that a higher level of 
physical activity is associated with reduced cardiovascular outcomes 14,31–34, we 
wanted to study whether the benefits of physical activity were measurable on 
myocardial function.   
 
Aim of study I:  
a. Explore whether the level of physical activity was associated with better 
cardiac performance assessed by tissue Doppler echocardiography.  
 
 
Study II 
Physical activity is associated with a reduction in mortality and cardiovascular 
events. Intervention trials including persons with hypertension undergoing training 
protocols have documented that regular exercise reduces BP 35–38.  
We wanted to study whether these two associations were linked, that is, whether 
physical activity improves prognosis in hypertension. 
 
Aims of study II 
a. Explore whether physical activity is associated with a reduction in 
mortality and cardiovascular events in hypertension. 
b. Explore whether this association was present in a dose-response pattern. 
 
 
Study III 
LVH is a complication of hypertension and a strong predictor of cardiovascular 
outcome 39–44. Physical activity is also associated with higher LVM 45–48. Previous 
studies have described that physical activity is beneficial in hypertension 49,50. The 
associations between physical activity, LVM, and prognosis in hypertension vs 
normal BP need to be clarified. 
 
Aims of study III 
a. To study whether the presence of hypertension modified the association 
between level of physical activity and LVM.  
b. To explore whether the association between the level of physical activity 
and long-term prognosis in hypertension was modified by LVH. 
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METHODS 
The Copenhagen City Heart Study (in Danish “Østerbroundersøgelsen”) is a large 
cardiovascular prospective cohort study launched in 1976 by Dr Peter Schnohr, Dr 
Gorm Boje Jensen, Statistician Jørgen Nyboe, and Professor Anders Tybjærg Hansen 
51. Inspired by the Framingham Heart Study, the main purpose of the study was to 
explore coronary heart disease — mechanism, prognosis, and prevention 52. 
However, during the past decades, many other medical areas have been added to 
the study: genetics, pulmonary diseases, arthrosis, echocardiography, heart failure, 
psychosocial factors, dementia, and more.  
The study was based at Rigshospitalet from 1975 to 1997. In 1997, the study was 
re-located to Bispebjerg Hospital. Since 2012, the study has been housed by 
Frederiksberg Hospital.  
 
Study population 
As of 1st January 1976, a random sample of 19,329 men and women aged 20-93 
years living within a well-defined area of the inner Copenhagen City boundary was 
drawn from the Central Office of Civil Registration and invited to take part in the 
study. The selection of the area was made by the distance of 10 wards surrounding 
Rigshospitalet, where the study was located. Thus, entire Østerbro and one-third of 
Nørrebro were included. Approximately 90,000 inhabitants were living in this area 
in 1976 (Figure 1 – Copenhagen) 53–55. The sample of 19,329 men and women was 
stratified in 5-years age groups, and the main emphasis was on the age groups 
from 35 to 70 years. In total, 14,223 persons agreed to participate in the first 
examination (response rate 73.6%, Figure 2 — flow chart).  The second survey was 
carried out in 1981-83, the third in 1991-94, the fourth in 2001-03, and the fifth in 
2011-15. All subjects from the original sample were invited to all subsequent 
examinations, and a new random sample of men and women from the same area 
in Copenhagen was included each time. The numbers of invited persons and 
response rate are given in Figure 2. The present thesis included data from the first 
four surveys of the Copenhagen City Heart Study. All subjects gave informed 
consent to participate. The study was performed in accordance with the second 
Helsinki Declaration and approved by the regional ethics committee (KF 
100.2039/91).   
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Figure 1. 
Map of Copenhagen.  
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Figure 2. 
Flow chart illustrating the participation in the Copenhagen City Heart Study. 
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Self-administered questionnaire 
At each survey, all participants completed a health questionnaire regarding 
information on their medical history, socioeconomic status (education, income, 
marital status), health status, symptoms and level of physical activity in work and in 
leisure time 52. The questionnaire was checked by a health professional when the 
participants came to the health examination.  
 
 
Physical activity questionnaire 
A physical activity questionnaire was a part of the self-administered questionnaire, 
and the same physical activity questionnaire was used in all four examinations. A 
single question with four categories was applied for measuring leisure-time 
physical activity:  
 
Please indicate your PHYSICAL ACTIVITY LEVEL IN YOUR SPARE TIME (including 
transportation to and from work) over the last year (choose one option only) 
 
I Almost completely physically passive or physically active for less 
than 2 hours per week 
e.g., reading, watching TV, going to the cinema 
 
 
II Light physically activity 2-4 hours per week                     
e.g., walking, cycling, light garden work, or low-intensity 
workouts 
                                                                         
 
III Light physical activity more than 4 hours per week or more 
strenuous activity 2-4 hours per week 
e.g., fast walking and/or fast cycling, heavy garden work, high-
intensity workouts involving getting sweaty and short of breath                                                                                                                                
 
IV More strenuous physical activity for more than 4 hours per 
week or regular high-intensity workouts or sporting 
competitions several times per week 
 
 
 
 
In the present studies, the activity levels were categorised into the following levels 
according to the questionnaire: 
I. Inactivity. (intensity: < 3 metabolic equivalents (METs) (Used as reference group)  
II. Light activity.  (intensity: 3-4.5 METs)  
III. Moderate activity. (intensity: 4.5-6 METs)  
IV. High-level activity. (intensity: >6 METs)  
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Health examination 
Besides the health questionnaire, the participants underwent a physical health 
examination, including blood samples and an electrocardiogram, at each of the 
surveys.  
 
Height and weight 
Height was measured without shoes on a fixed scale to the nearest millimetre. 
Weight was measured without outdoor clothing and shoes on a Seco Consultation 
Scale, to the nearest hectogram 56. Body mass index (BMI) was calculated by 
dividing weight with height². The classes of BMI were defined as follows: 
underweight (BMI<18.5 kg/m²), normal weight (BMI 18.5-24.9 kg/m²), overweight 
(BMI 25.0-29.9 kg/m²), obesity (BMI ≥30.0 kg/m²).  
 
Blood pressure 
The measurement of BP was performed under highly standardised circumstances 
and was unchanged in all four surveys. All equipment was tested at regular 
intervals between the surveys. The guidelines recommended by Rose & Blackburn 
were followed because these were the standards when The Copenhagen City Heart 
Study was initiated 57. Trained technicians used a London School Hygiene 
Sphygmomanometer (Figure 3), which is a blind, mercury-column manometer 
designed to reduce observer bias and digit preference 58,59. The subject was seated 
on a comfortable chair, and the back was supported. The arm was supported with 
the antecubital fossa at heart level. A cuff was applied to the non-dominant arm. 
The size of the cuff was chosen from the upper arm circumference. After 5 minutes 
of rest, BP was measured once. The mercury fall was 2 mm/s. The first Korotkoff 
sound (the sounds are first heard) defined the systolic BP. The diastolic BP was 
defined by the fifth Korotkoff sound (the sound disappears).  
The BP levels were defined according to the seventh Joint National Committee 60: 
 
 
Normal BP: systolic BP < 120 mmHg and diastolic BP < 80mmHg. 
Pre-hypertension: systolic BP between 120-139 mmHg or diastolic BP between 80-
89 mmHg. 
Stage I hypertension: systolic BP between 140-159 mmHg or diastolic BP between 
90-99 mmHg, or receiving pharmacological treatment for hypertension with 
systolic BP < 160 mmHg/ diastolic BP < 100 mmHg.  
Stage II hypertension: systolic BP ≥160 mmHg or diastolic BP ≥ 100 mmHg. 
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Figure 3 
Photos of the London School of Hygiene Sphygmomanometer used in the 
Copenhagen City Heart Study. Explanations in Danish. Source: The Copenhagen City 
Heart Study, Frederiksberg Hospital.  
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Echocardiography 
A total of 3,654 randomly selected persons from the fourth Copenhagen City Heart 
Study underwent conventional transthoracic echocardiogram. The tissue Doppler 
imaging was performed in 2,221 of these participants (Figure 4). 
All participants followed the same procedure for the health examination. 
Echocardiographic examination was performed at the last examination station, and 
the sonographer was blinded to the results of the previous examinations. The 
collected images were stored for later analysis. In case of more than three persons 
waiting for the last station, the last arriving persons were sent home. None of the 
participants declined to undergo echocardiography 56.  
 
 
Conventional echocardiography 
All conventional echocardiographic measures were made by investigators blinded 
to other information. Recommendations from the American Society of 
Echocardiography were used to assess left ventricular (LV) regional and global  
function 61.  
Assessment of left ventricular mass 
In the parasternal long axis, one loop was recorded. One M-mode still frame 
between the tips of the mitral leaflets and the tips of the papillary muscles was also 
stored. Posterior wall thickness, LV diameter, and septal wall thickness were 
assessed in end-diastole. If it was not possible to assess the dimensions in M-mode 
trace, 2D images were used (Figure 5). LVM was calculated using the Devereux 
formula 62,63. Left ventricular mass index (LVMi) was quantified as the anatomic 
mass divided by the body surface area 64. Definition of LVH was: LVMi>115 g/m² for 
men and >95 g/m² for women 65.  
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Figure 4.  
Flow chart, echocardiography in the fourth Copenhagen City Heart Study.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1,433 persons did not undergo 
tissue Doppler echocardiography 
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Figure 5.  
Assessment of LV dimensions by M-mode (top), or 2D images (bottom). 
Source: ‘Recommendations for Cardiac Chamber Quantification by 
Echocardiography in Adults: An Update from the American Society of 
Echocardiography and the European Association of Cardiovascular Imaging’, R.Lang 
et al., 2015, Journal of the American Society of Echocardiography 
 
 
 
 
Tissue Doppler imaging 
Colour tissue Doppler Imaging (TDI) loops were achieved at the highest possible 
frame rate (median 133; interquartile range 37 frames/sec) in the three apical 
views: 4-chamber, 2-chamber, and long axis. Investigators blinded to all other 
information analysed the images using ECHOPAC, GE Medical, Horten, Norway. 
Myocardial velocities were measured with a 6 mm circular sample volume placed 
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at the end of ejection. Peak systolic (s´) and diastolic (e ´) mitral annular velocities 
were assessed (Figure 6). Longitudinal displacement (LD) was calculated as the 
integral of the velocity curve during ejection. Cardiac time intervals include 
isovolumetric relaxation time (IVRT), isovolumetric contraction time (IVCT), and 
ejection time (ET). Myocardial performance index (MPI) was calculated: (IVRT+ 
IVCT)/ET. The cardiac time intervals in the present studies were measured using 
colour tissue Doppler imaging M-mode line through the mitral leaflet (Figure 7).  
 
Diastolic function evaluated by e` 
In study I, we chose e` to evaluate the diastolic function of the LV. While systolic 
function is easily evaluated by ejection fraction (EF) or deformation techniques, 
evaluation of LV diastolic function remains a clinical challenge because there is no 
single clinical measure that quantifies LV diastolic function 66,67.  The myocardial 
velocity in early diastole (e  ̓) reflects LV regional lengthening and is a cornerstone 
in evaluating diastolic function because it covers both relaxation and restoring 
forces 66,68. In heart failure, e  ̓ is less load-dependent compared with transmitral 
velocities 69. In contrast to E/A-ratio in Doppler echocardiography, e  ̓ is a 
continuous parameter easy to interpret, where high values usually reflect normal 
diastolic function, except for rare conditions such as constrictive pericarditis 69,70. 
 
Systolic function evaluated by Longitudinal Displacement 
LD, also called mitral annular longitudinal displacement due to the movement of 
the mitral plane towards the apex, is equivalent to longitudinal systolic shortening 
71. LD differentiates myocardial dysfunction more precisely than LVEF 72,73. Besides, 
LD is a sensitive and early marker of both heart failure and other structural heart 
diseases 74. LD correlates with stroke volume and is, thus, also dependent on heart 
rate 75.  
 
Myocardial Performance Index 
MPI reflects the combined diastolic and systolic function of the LV. This is 
practically defined by the opening and closure of the heart valves, and has drawn 
attention and been measured with many different techniques: stethoscope and 
sphygmography in the 19th century to M-mode and pulsed Doppler 
echocardiography in the late 20th century to TDI echocardiography in the early 21st 
century 76. The tissue Doppler method with M-mode line through the mitral leaflet 
has been described in detail and validated in previous studies 76–78. In an unhealthy 
heart, the time from mitral valve closure to aortic valve opening (IVCT) might be 
prolonged due to longer time for the myocytes to achieve the pressure equal to 
that of the aorta. ET will be shortened because the sick myocardium will not be 
able to keep the systolic pressure for a long time. As diastolic dysfunction proceeds, 
the IVRT (time from aortic valve closure to mitral valve opening) will be prolonged 
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due to impairment of the diastolic function. MPI will, thus, increase in a 
dysfunctional myocardium 78,79.  
 
 
 
 
Figure 6 
Myocardial velocities, TDI. Early (e’) and late (a’) diastolic peak is marked. LD 
/mitral annular displacement is calculated from the area under the curve during 
systole (shaded area).  
Source: ‘The association between physical activity and cardiac performance is 
dependent on age: the Copenhagen City Heart Study. ’ Joseph G et al. Int J 
Cardiovasc Imaging [Internet]. 2019 
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Figure 7 
Cardiac time intervals assessed by colour tissue Doppler imaging M-mode line 
through the mitral leaflet during end-systole. MVC: mitral valve closing. AVO: aortic 
valve opening. AVC: aortic valve closing. MVO: mitral valve opening. IVCT: 
isovolumetric contraction time. IVRT: isovolumetric relaxation time. ET: ejection 
time.  
Source: ‘The association between physical activity and cardiac performance is 
dependent on age: the Copenhagen City Heart Study.’ Joseph G et al. Int J 
Cardiovasc Imaging [Internet]. 2019 
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The Danish registries 
CRS and NPR 
A Civil Personal Register number (CPR) is a register linkage in all medical and 
administrative registers in Denmark 80,81. A CPR-number is assigned by the Danish 
Civil Registration System (CRS), which provides information on the residents` 
migration and vital status: birth, citizenship, marital status, residence, emigration 
date, death date and more. Manual national registration of Danish residents was 
established in 1924, and the CRS in the electronic form as we know it today was 
established on 2 April 1968 82. The Danish National Patient Register (NPR) was 
established in 1977 and is internationally considered to be the most 
comprehensive of its kind 80. In the beginning, only somatic inpatient contacts were 
registered. From 1969, psychiatric admissions were added, and from 1995, all 
emergency room contacts, as well as all outpatient contacts, were included. In 
1994, Denmark adapted the International Classification of Diseases, version 10 
(ICD-10). 
 
Danish Death Cause register 
It has been mandatory by law to complete a death certificate upon any case of a 
death occurring in Denmark since 1871 83. In 1970, the death causes were gathered 
in a central register by information collected from the manually completed death 
certificates. Before electronic registration, the codes were centrally validated by 
specially trained coding personnel in the National Board of Health. Since 2007, 
death certification has been submitted by an electronic form to the National Board 
of Health, and thus the ICD-codes are registered directly by the physical completion 
of the death certificate without central validation of the death causes. ICD-10 
codes, as recommended by WHO, have been used since 1994.  
 
Follow-up and outcome 
All persons who participated in the Copenhagen City Heart Study were followed in 
the Danish registries regarding information on hospital contacts, death date, and 
death causes. The diagnostic information was coded according to ICD-8 until 1994, 
and afterwards, ICD-10. The date of death was collected from CRS and is updated 
daily centrally. The data on hospital admissions were collected from NPR and has a 
delay of two weeks on updates. The information in the Danish Death Cause 
Register has a delay of two years on updates. The end-date of follow-up for death 
date (CRS) and hospital admissions (NPR) was 19 April 2018 for study II and 13 
December 2018 for study III. The end-date for follow-up for death causes was 31 
December 2016 for both study II and study III.   
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In studies II and III in this thesis, we used the following ICD-8 codes and ICD-10 
codes in NPR for defining cardiovascular events (admission or death due to acute 
myocardial infarction (AMI), heart failure, or stroke): ICD-8: 410-414; 42709-42711; 
42719; 430-438. ICD-10: I20-I25; I50; J81; I60-I68; G45.  
Previous cardiovascular disease (CVD) was defined as previous AMI or stroke 
reported by the participant in the questionnaire or registration of one of the 
above-mentioned ICD-codes in NPR before entering the Copenhagen City Heart 
Study for the first time. 
 
 
Statistics 
Study I 
The association between the level of physical activity and cardiac function was 
analysed by linear regression models considering the level of physical activity as a 
categorical variable. Because tissue Doppler parameters are dependent on age, the 
analyses were made in the following age strata: < 50 years, 50-65 years, and > 65 
years. Interaction analyses were performed in the multivariable regression models 
separately for each of the echocardiographic parameters to clarify whether age 
interacted in the association between the level of physical activity and cardiac 
function.  
The assumptions for linear regression model were tested within each age group: 
Linearity, variance homogeneity, and normality. Normality was tested with plots of 
residuals.  
We adjusted for following confounders: sex, ischemic heart disease, hypertension, 
BMI, and diabetes. Additionally, we also adjusted for resting heart rate (RHR) 
because RHR might affect TDI-values.  
 
Study II  
Cox regression model with time-dependent covariates was used to assess the 
association between the level of physical activity and the outcome in each of the 
BP groups. Thus, both exposures (level of physical activity and BP level) and 
confounders could potentially change over time for each of the persons included in 
this study. The underlying time scale was age. Besides, the following covariates 
were considered confounders: sex, smoking status (never smoker, former smoker, 
1-14 g tobacco/day, ≥15g tobacco/day), education (<8 years, 8-10 years, ≥11 years), 
diabetes, previous CVD, class of BMI (underweight [BMI, <18.5 kg/m²], normal 
weight [BMI, 18.5–24.9 kg/m²], overweight [BMI, 25.0–29.9 kg/m²], and obesity 
[BMI ≥30.0 kg/m²]). Furthermore, all models were adjusted for calendar time. 
When assessing cardiovascular events (admission or death due to AMI, heart 
failure, or stroke), death from other causes was considered as competing events. 
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This outcome was assessed with both Cox regression analysis and Fine-Gray 
subdistribution hazard regression analysis.  
 
Study III 
Linear regression models were used to assess the association between the level of 
physical activity and LVMi. Trend and interaction were analysed using the likelihood 
ratio test. All-cause mortality and cardiovascular events were assessed by 
cumulative incidence curves and by Cox proportional hazards regression analysis. A 
supplementary, Fine-Gray subdistributional hazard regression analysis was used for 
confirming the results for cardiovascular events considering death from other 
causes as a competing event. Following covariates were considered as 
confounders: sex, age, previous CVD, smoking status (never smoker, former 
smoker, current smoker), diabetes mellitus, and total cholesterol.  BMI was not 
included as a confounder, because body surface area was used to calculate LVMi 
and define LVH. 
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RESULTS 
Physical activity in the Copenhagen City Heart Study 
In all four surveys, light activity was the most predominant activity level (Table 1, 
Figures 8-9). The percentage of moderate activity increased from 24% in survey 1 
to 34% in survey 4. The percentage of persons in inactivity group decreased from 
20% (survey 1) to 13% in survey 4.  
This might be due to the increased health awareness over time and greater 
knowledge of the health benefits of physical activity.  
When we study the distribution in each age group, it seems that light activity is the 
most predominant activity level in all age groups in all four surveys. However, in 
age 20–50 years, the percentage of high activity increased from 3% (survey 1) to 
8% in survey 4. The percentage of inactivity increased with higher age in all four 
surveys; however, fewer persons were in this category in each age group over time.  
 
Table 1.  
Trend of physical activity in each of the four surveys. 
 
 Exam 1 Exam 2 Exam 3 Exam 4 
Inactivity, 
no. (%) 
2,838 (20) 2,192 (17) 1,343 (13) 596 (10) 
Light activity,  
no. (%) 
7,692 (54) 6,104 (48) 5,307 (53) 3,157 (51) 
Moderate 
activity, no. (%) 
3,436 (24) 4,099 (32) 2,996 (30) 2,125 (34) 
High activity, 
 no (%) 
241 (2) 294 (2) 344 (3) 295 (5) 
Total, 
no (%) 
14,207 (100) 12,689 (100) 9,990 (100) 6,173 (100) 
 
 
 
 
 
 
 
 
 
 
 
 
 Population study of Physical Activity  
42 
 
Figure 8. 
Distribution of level of physical activity in the first four surveys of the Copenhagen 
City Heart Study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. (next page) 
Distribution of level of physical activity in the first four surveys of the Copenhagen 
City Heart Study, stratified by age groups.   
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Study I 
In all three age categories, the majority had a light activity level, and only a few had 
a high activity level (Table 1). Higher age group was associated with worse tissue 
Doppler parameters. In age< 50 years, increased levels of physical activity were 
associated with better cardiac performance. In age > 65 years, there seemed to be 
a tendency for worse cardiac function (MPI) at higher activity levels.  
 
Table 2.  
Distribution of the participants across age strata and activity levels.  
 
 Age < 50 
years 
Age 50-65 
years 
Age >65 
years 
In total 
I: Inactivity,  
no. (%) 
53 (8) 47 (7) 80 (11) 180 (9) 
II: Light activity,  
no. (%) 
263 (41) 318 (48) 435 (57) 1,016 (49) 
III: Moderate  
activity, no. (%) 
261 (41) 269 (41) 223 (29) 753 (37) 
VI: High activity,  
no. (%) 
57 (9)   25 (4) 22 (3) 104 (5) 
In total, no (%) 634 (100) 659 (100) 760 (100) 2,053 (100) 
 
 
Figure 10.  
Diastolic function. 
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Figure 11.  
Systolic function. 
 
 
 
Figure 12.  
Combined diastolic and systolic function. 
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Study II 
Level of physical activity was associated with a dose-response reduction in 
mortality at all BP levels. Compared with inactivity, any level of physical activity was 
associated with a reduction in cardiovascular events at all BP levels. Most of the 
health benefits were achieved already at the light activity level.  
 
Table 3.  
Distribution of the participants in each of the BP levels and activity levels. 
 
 Inactivity Light activity Moderate/ 
high activity 
Total 
Normal BP, 
no. (%) 
491 (13) 1,864 (51) 1,288 (35) 3,643 (100) 
Pre-hyp., no. 
(%) 
1,143 (17) 3,374 (51) 2,105 (32) 6,622 (100) 
Stage 1 hyp., 
no. (%) 
1,104 (21) 2,666 (51) 1,472 (28) 5,242 (100) 
Stage 2 hyp,  
no. (%)  
681 (22) 1,639 (53) 765 (25) 3,085 (100) 
 
 
 
Figure 13. 
All-cause mortality. Event rate. In the table below: No. of observations, and in 
parenthesis, no. of events. 
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Figure 14.  
Cardiovascular events. Event rate. In the table below: No. of 
observations, and in parenthesis, no. of events. 
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Study III 
1. LVMi was significantly higher in hypertension compared with normal BP 
(Figure 15).  
2. Hypertension modified the association between the level of physical 
activity and LVMi. Thus, a higher level of physical activity was associated 
with increased LVMi in normal BP, whereas this association was not found 
in hypertension (Figure 15). 
3. Physical activity was associated with a reduction in mortality and 
cardiovascular events. This association was not modified by the presence 
of LVH (Figure 16–17). 
4. The impact of LVH on prognosis was not modified by higher physical 
activity levels (Figure 18).  
5. BP level did not modify the impact of LVH on prognosis; thus, LVH was 
associated with worse outcome in both normal BP and in hypertension 
(Figure 19). 
6. LVH remained an independent predictor of mortality and cardiovascular 
events (Figure 20). 
7. Level of physical activity was an independent predictor of reduced 
outcome (Figure 20). 
 
 
 
Table 4.  
Distribution of the participants according to the BP levels and activity levels. 
 
 Inactivity Light 
activity 
Moderate/ 
high activity 
Total 
Normal BP, 
no. (%) 
109 (6) 764 (45) 829 (49) 1,702 (100) 
Hypertension, 
no. (%) 
129 (9) 762 (55) 485 (35) 1,376 (100) 
Total, no. (%)  238 (8) 1,526 (50) 1,314 (43) 3,078 (100) 
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Table 5 
Distribution of the participants according to presence of LVH and activity levels. 
 
 Inactivity Light 
activity 
Moderate/ 
high activity 
Total 
No LVH,  
no. (%) 
189 (8) 1,234 (49) 1,106 (44) 2,529 (100) 
LVH,  
no. (%) 
49 (9) 292 (53) 208 (38) 549 (100) 
Total,  
no. (%)  
238 (8) 1,526 (50) 1,314 (43) 3,078 (100) 
 
 
Figure 15.  
 
LVMi and activity level. 
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Figure 16. 
Cumulative incidence of all-cause mortality and cardiovascular events, according to 
the presence of LVH, stratified by the level of physical activity.  
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Figure 17. 
LVH, physical activity, and outcome. All-cause mortality and cardiovascular events 
according to the level of physical activity and presence of LVH. Adjusted for age, 
sex, diabetes mellitus, total cholesterol, previous CVD, smoking status, and 
hypertension.*P<0.05; **P<0.01; ***P<0.001. 
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Figure 18. 
Physical activity, LVH, and outcome. All-cause mortality and cardiovascular events 
according to the level of physical activity and presence of LVH. Adjusted for age, 
sex, diabetes mellitus, total cholesterol, previous CVD, smoking status, and 
hypertension. *P<0.05; **P<0.01; ***P<0.001. 
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Figure 19. 
BP level, LVH, and outcome. All-cause mortality and cardiovascular events 
according to the BP group and presence of LVH. Adjusted for age, sex, diabetes 
mellitus, total cholesterol, previous CVD, smoking status, and level of physical 
activity. *P<0.05; ***P<0.001. 
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Figure 20. 
All-cause mortality and cardiovascular events. Multivariable analyses are adjusted 
for age, sex, diabetes mellitus, total cholesterol, previous CVD, smoking status, and 
hypertension. *P<0.05; **P<0.01 ***P<0.001. 
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DISCUSSION OF THE METHODOLOGY 
Concerns about the invited population 
As illustrated in Figure 21, participants in a cohort study differ from the target 
population, to whom we want to address the overall study results.  
There might be selection bias at different levels from planning a cohort study to the 
individuals who participated in the specific studies.  
This was a population-based cohort-study which by its nature leads to selection 
bias because not everyone invited to the study will participate. Even though the 
persons invited to take part in the study were randomly selected, the study 
population consisting of persons who chose to participate might not necessarily 
represent a random sample. It is well-known that persons who chose to participate 
might be healthier than those who do not participate, leading to a systematic 
difference between these two groups 84. Those who usually chose to participate in 
a population study might thus belong the higher social class of the community 85.  
 
In the Copenhagen City Heart Study, the source population was inhabitants of inner 
Copenhagen, who were invited to take part in the surveys. The study sample (those 
who agreed to take part) is already a selected group. Different factors might affect 
who chooses to participate in a cohort study 86,87. If this is systematically dependent 
on exposure or outcome, this may lead to selection bias 85,88. However, not all 
exposure-outcome associations might be affected by selection bias 89. It is already 
shown that the distribution of mortality rates in some Danish cohort studies, 
including the Copenhagen City Heart Study, differ and are higher among the non-
participants compared with participants 90.  
 
 
Figure 21. 
The target population to whom we might want to address the results might differ 
from the study participants.  
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The population invited to take part in the Copenhagen City Heart Study was from 
Østerbro (2/3) and Nørrebro (1/3). Persons living in this part of Denmark, especially 
Østerbro, are usually healthier and wealthier compared with other parts of 
Denmark 2,91. This might raise concerns about how the results could be applied to 
the general population. It is well-described how both the prevalence of 
cardiovascular diseases and survival are dependent on social, educational, and 
economic factors 92–95. Physical activity, which is the main exposure in the studies 
included in the present thesis, is dependent on health awareness and 
socioeconomic status 92,96–98. Thus, the distribution of activity levels in the current 
study population might differ from other populations in Denmark.  
According to the Danish National Health Profile 2, the population in the Capital 
Region of Denmark, and especially in the areas of Østerbro and Nørrebro, has the 
highest adherence to the WHO recommendations on physical activity (Figure 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. (next page) 
Percentage of the population not fulfilling the WHO recommendation for physical 
activity. Source: Danish National Health Profile. 
http://www.danskernessundhed.dk/ 
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Even though the study population is not representative for the whole Danish 
population, it should be underscored that we studied associations between 
physical activity and  
1. cardiac performance (study I),  
2. long-term prognosis in hypertension (study II), and  
3. LVMi/LVH and prognosis (study III).  
The distribution of both exposure (physical activity/hypertension) and outcome 
(death/cardiovascular events) might differ across different socioeconomic classes, 
but the associations between these might be the same in other study populations 
from Denmark and in other parts of the world.  
Further, we additionally adjusted for potential confounders in the time-to-event 
analyses. In our analyses we included education as a measure of socioeconomic 
status and did not include annual income. In a Danish population, we believe, that 
education is a more sensitive marker of socioeconomic status than income. By this 
adjustment and additional adjustment for other factors which might affect the 
association between physical activity and cardiac function/outcome, we, therefore, 
hope that differences which might interfere in the association do not have a 
significant impact on the overall interpretation of the results.   
 
 
Missing variables and non-responders 
 
The participants in the specific studies differ further because usually only persons 
without missing variables on the defined exposure are included. It is important in a 
cohort study to clarify whether the missing information could also be a sign of bias. 
That means, whether persons with missing covariates have more comorbidities as 
this might lead to exclusion of the sickest persons in the analyses. 
 
Another concern is the characteristics of the participants who do not attend the 
follow-up surveys. Once entered the Copenhagen City Heart Study, all participants 
were invited to the subsequent surveys, and each time a new number of 
participants were included (Figure 2). Those who do not participate (non-
responders) might differ in both exposure and outcome, compared with those who 
participate in the following examinations. In selective drop-out, results might be 
affected dependent on associations examined 84. Those exhibiting worse health 
might not participate in subsequent surveys, either because of 1) their health 
status or inability to participate or 2) other reasons, such as social factors, making 
them uninterested in participating. 
A previous study has described how the non-responders in the Copenhagen City 
Heart Study have a worse prognosis compared with the persons who attend the 
subsequent examinations 99.  
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Persons who underwent echocardiogram 
Persons who underwent echocardiogram were randomly selected from the study 
population of the fourth survey. Their health status did not determine whether 
they underwent an echocardiogram. The technicians who performed the 
echocardiograms and the investigators analysing the images were blinded to the 
participants´ health information. The participants who underwent TDI were a 
random sample, as well. In Paper I, we studied the population who underwent TDI 
(N= 2,221), and in Paper III, we studied all persons who underwent conventional 
transthoracic echocardiograms (N=3,654). The population sample who underwent 
TDI was a random sample (N=2,221) of those who underwent conventional 
transthoracic echocardiogram (N=3,654) (Figure 4.) To confirm that these two 
echocardiographic populations were random samples, we made sensitivity analyses 
by performing the time-to-event analyses for those who underwent TDI vs. 
conventional echocardiogram only (prior to publication of Paper III). The results 
exhibited the same pattern.  
 
 
Blood pressure 
Casual BP measurement 
In the present studies, a single BP measurement (casual BP) on the non-dominant 
arm was performed under highly standardised circumstances as described by Rose 
& Blackburn 57. The circumstances were unchanged in all four surveys. Current 
guidelines recommend that BP is measured under standardised circumstances 
more than once, on both arms, and additional measurements are required if the 
first two readings differ by >10 mmHg 100. Thus, casual BP is not the best method to 
diagnose or grade hypertension status. However, casual BP has been widely used in 
other large epidemiological trials and suggested by Rose & Blackburn as a feasible 
method. Casual BP is a reliable predictor of hypertension and risk of stroke and 
other CVD 101,102. A study from Framingham also described casual BP as highly 
predictive of future cardiovascular events in an epidemiological setting, even 
though a single BP measurement does not provide a precise characterisation for 
each person 103.   
 
Trends of BP in the study population 
A previous study performed by Andersen et al. in 2004 showed that the study 
population from the Copenhagen City Heart Study had a decrease in systolic BP 
over time 104. The decrease was independent of major cardiovascular risk factors 
and increasing alcohol intake 105. The level of physical activity did not explain the 
declining population BP 106. However, even though this trend reflected a decline in 
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mortality risk in the younger and middle-aged part of the population, the effect of 
systolic BP on mortality remained the same 107. Women with a higher economic 
income had significantly lower systolic BP compared with women in a low-income 
group 108. This difference seemed to increase with time. This pattern was not found 
among men. No income-associated differences were found in the pharmacological 
treatment of hypertension.  
Daytime variations in both systolic and diastolic BP have also been described, but 
these differences were not found after adjustment for age 109. There were also 
seasonal variations since there was a tendency of higher BP during winter. 
However, the examinations, including BP measurements, took place in all seasons, 
minimising the importance of seasonal variations.  
 
Blood pressure medication 
The definition of hypertension and BP levels are based on the measurement at 
baseline. We do not know if the persons who were diagnosed with hypertension at 
baseline started antihypertensive medication during the follow-up, and how this 
would affect the results. Especially for study III, it might be of importance, because 
some medications, especially medications affecting the renin-angiotensin system, 
might reduce LVM independent of the reduction in BP 110,111. It would have been 
desirable if we applied for data from the Danish National Prescription Registry 112, 
which is a registry covering individual-level data on prescriptions for Danish 
residents. This registry was established in 1994, and detailed information on the 
pharmacological prescriptions have been registered since 1995. Because the 
Copenhagen City Heart Study started in the 1970s, we could not have medication 
data from the registry for study II, but for study III, it would have been possible. 
However, this was not made because of the well-known very long waiting time 
from formal application to possible granting of access to the data.  
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Physical activity in work time 
In the present studies, we studied the physical activity only in leisure time. We did 
not include occupational physical activity. The main reason was that many persons, 
especially persons aged >60 years, had missing information on the variable 
determining level of physical activity in work, because many persons >60 years are 
usually retired from work. Besides, the levels of physical activity in leisure time and 
work time might not be comparable in terms of cardiovascular prognosis. Persons 
having high physical demands at work are at higher risk of atherosclerosis 113,114 
and have higher levels of systolic BP 115. Previous studies have described that this 
part of the population has a higher risk of cardiovascular events and all-cause 
mortality 116. Physical activity in leisure time promotes health, while occupational 
physical activity impairs health, a phenomenon named the ‘physical activity 
paradox’  117. Thus, not including physical activity level in work time seems 
reasonable in the present studies.  
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Reporting bias: self-reported physical activity 
The level of physical activity was self-reported. Since this is a prospective cohort 
study, we do not assume there is a recall bias, but there might rather be a reporting 
bias. The causes could be social desirability, inaccurate memory, or the inability to 
evaluate the absolute activity level 118. This induces a limitation to self-reported 
activity concerning reliability and validity 119. The question is, whether there is a 
systematic error in the ways the exposed (active) group and the unexposed 
(inactive) groups reported their activity level. One might suspect that most people 
tend to overestimate their level of physical activity. Many persons might have a 
desire to increase their level of physical activity, and this might affect the reporting, 
especially among those in the inactivity or light activity group 120. 
Direct/objective measures might provide precise estimates of energy expenditure 
and remove reporting bias. Direct measures could be calorimetry, physiologic 
markers (i.e., cardiorespiratory fitness), and motion sensors/monitors (i.e., 
accelerometers) 121,122.   
The questionnaire used in this study was described by Rose & Blackburn 57 and 
Saltin & Grimby 123, later used in modified versions in other Nordic countries 124, 
where it was found to be sufficiently reliable and valid to monitor physical activity 
levels in the population. Other studies comparing the association between the 
objectively measured level of physical activity and self-reported activity concluded 
that study participants reported more vigorous activity and less sedentary time 
compared with accelerometer data 121.  
In the fifth survey of the Copenhagen City Heart Study, accelerometers were used 
to assess physical activity in 2,335 persons 125. In the future, it would be possible to 
compare and validate the self-reported physical activity data in the study 
population of the Copenhagen City Heart Study.  
 
Duration of level of physical activity 
Persons having a high BP at the examination were told to contact their general 
practitioner to remeasure the BP and evaluate the need for medical treatment. It is 
possible that these persons, with time, became more aware of their health status 
and thus changed their health behaviour including increasing their level of physical 
activity afterwards. This could probably affect the results. Further, participating in a 
cardiovascular population study might also affect the health awareness.  
In the physical activity questionnaire, the participants were asked to grade their 
level of physical activity for the last year. In the longitudinal studies, we assumed 
that these activity levels were present until the date of an event/censoring or the 
next survey. We cannot, of course, be sure that the persons did not change their 
level of activity. Previous publication from the Copenhagen City Heart Study 
described that more than half of the study population remained in the same 
activity level between two surveys 126. Our study results are very consistent in the 
 Population study of Physical Activity  
65 
 
association between level of activity and outcome. Additionally, previous studies 
with self-reported activity showed similar results 10,127,128.  
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STUDY-SPECIFIC DISCUSSION 
Discussion study I 
Study design: Analytical cross-sectional study 
Cross-sectional studies are a snapshot of the study population. Cross-sectional 
studies, also called, prevalence studies, can either be descriptive or analytical. In 
the analytical study, both exposure and outcome are measured at the same time 
point 129. By their nature, cross-sectional studies are not the most suitable for 
concluding any causality, especially because of the uncertainty of durance of the 
exposure 130. Study I in this thesis is an analytical study, where exposure is the level 
of physical activity and outcome is cardiac function. We considered the level of 
physical activity as a stable exposure. However, according to the physical activity 
questionnaire, the participants were supposed to select the activity level that was 
appropriate for their physical activity during the past year. So, the actual exposure 
is the level of physical activity for the past year. The outcome is the cardiac 
function measured by tissue Doppler echocardiography.  
 
Another important issue in cross-sectional studies is, whether the exposure or the 
outcome came first 131. In the present study, it means, whether we believe that the 
cardiac function reflected the level of physical activity, or if better cardiac 
performance lead to higher physical activity level. The latter assumption would 
make no sense. However, we should remember, that persons in better health are 
able to perform higher levels of activity.  
 
Statistics and confounders 
The results presented in the figures for e`, LD, MPI, and RHR in the paper were 
mean and 95% confidence intervals (CI). It would have been better to present the 
adjusted means and 95% CI, after adjustment for all confounders. The presented p-
values for the trend tests are p-values in a multivariable trend test (multivariable 
linear regression where physical activity was considered as a continuous variable). 
It would have been more appropriate to use a likelihood ratio test for trend 
analysis.  
RHR does not fulfil the criteria for being a confounder (associated with both 
exposure and outcome without being an intermediate) 132. Lower RHR might rather 
be a physiologic consequence of high activity level. However, we chose to adjust 
for RHR in the multivariable model because the tissue Doppler values are related to 
RHR 133,134. Especially, cardiac time intervals are sensitive to changes in the heart 
rate. 
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It would also have been interesting and relevant to adjust for the continuous 
systolic/diastolic BP or mean arterial BP because this might determine the peak 
values of tissue Doppler parameters 135,136. We adjusted for hypertension vs normal 
BP as a binary variable in the published paper. Sensitivity analyses with adjustment 
for continuous BP did not change the results presented in Paper I. These analyses 
were made after the publication. 
 
Age, physical activity, and cardiac function 
When I presented the results from study I at meetings and congresses, the older 
part of the audience usually chose to interpret the results, as saying that persons > 
65 years do not have to be physically active. However, even if the conclusion is that 
the association between physical activity and cardiac function is modified by age, 
this cannot be a causal correlation.  
 
First, the study is performed in a cross-sectional study design. Second, we do not 
know for how long a time the participants had their reported level of physical 
activity. Third, we do not know whether each participant`s own classification of 
their level of physical activity is dependent on their age. The fact, that the activity 
level is self-reported is also an important detail, which is addressed previously in 
this thesis. We should also be aware of the fact that persons still alive at age > 65 
years and who are able to perform physical activity are already a selected healthy 
group. Their health status is not only dependent on their cardiac function but also 
other factors keeping them in a good life and health status. Even though MPI shows 
a sign of deterioration in cardiac function, it should not discourage one from 
exercising. Besides, the benefits of physical activity might be induced through many 
several physiological mechanisms apart from cardiac function, which is why the 
results should be interpreted with precautions. We assume that the main reason 
for the interaction between age and activity level is that an ageing heart and 
myocardium might be less capable of changes due to physical activity compared 
with a younger myocardium.  
 
The echocardiograms were performed at rest. Thus, the echocardiographic 
parameters reflect the cardiac function at rest. It would be interesting to study the 
same measures during exercise to evaluate how well the measures in rest correlate 
with the cardiac function during stress.  
 
In our study, we found different trends in MPI for both the younger (<50 y) and 
elder (>65 y) age groups. When analysing MPI, we found that the changes in these 
age groups were primarily driven by IVRT. Diastolic function is an important 
determinant of aerobic fitness and IVRT is a sensitive marker in evaluating LV 
diastolic function in terms of exercise. Our finding is comparable with results 
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reported by Libonati and colleagues regarding changes in both Tei-index and IVRT 
137–139.  
 
However, from an academic point of view, this study contributes slightly to the 
ongoing modern discussion about the theme, if too much physical activity could be 
dangerous, even though this concern has mainly been raised about persons at 
younger age performing sports on a competitive level 26,140,141. Concluding from our 
study that physical activity is dangerous would be unfair. 
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Discussion study II 
Study design II: Observational cohort study 
Study II and the second part of study III were performed in a cohort study design. 
The main criterion a cohort study should fulfil is that the unexposed should be 
similar in the characteristics to the exposed, with the exception of not having the 
exposure 142,143. As in many other cohort studies, this criterion was not fulfilled for 
the present studies. Persons in light/moderate/high activity were the exposed 
groups, and sedentary persons were defined as the unexposed. These groups 
differed significantly from each other in terms of health profile and socioeconomic 
status. This was, however, an expected finding.  
 
Physical activity is a measure of the health profile, as well as socioeconomic status. 
These three subjects are linked with each other and make natural differences in the 
description of the study populations. Controlling for confounding is therefore very 
important.  
 
The differential loss to follow-up between exposed and unexposed can bias the 
results. Fortunately, the unique features of the Danish registries made it possible to 
follow every person in the cohort until end of follow-up, date of death, or event. 
Only 1.1% of the study population emigrated, and they were followed until the 
date of emigration.  
 
 
Stratification on BP level 
There was a dose-response association between the level of physical activity and 
mortality at all levels of BP. This means that there was no interaction between 
physical activity and BP level on the outcome. So, practically and statistically, the 
analyses could be performed as a pooled analysis without stratification on the BP 
level. However, we chose to perform the analyses in each of the BP levels. The 
reason was, in the case that all BP levels are pooled, the assumption would be that 
the confounders have the same impact on every person regardless of the BP level. 
This means, that e.g. BMI-class or smoking status have the same impact on the 
prognosis for a person in normal BP as for a person in stage 2 hypertension. This 
might not necessarily be the case since there might be interaction between the 
covariates and the levels of BP on the outcome. Because BP level is a strong 
prognostic marker, the most appropriate method will be stratification on BP level in 
the way we chose to do, even though a pooled analysis could be justified 
statistically.  
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When to stop the follow-up? 
The number of years between the four surveys differed by 5 to 10 years. Not all 
persons continued in all subsequent surveys once they entered the study. Some of 
them were absent from one or more of the subsequent surveys. We decided to 
follow the participants until the date of an event or April 2018 once they had 
entered the study. When the statistical analyses were performed, the latest 
covariates were considered valid until the next time the participant attended a 
survey or until the end of follow-up if the participant did not attend further 
surveys. If we had decided to make censoring when a subject did not attend the 
following survey, this study would have a significant bias in only following a 
survival-cohort which is not representative of the general population. However, we 
made sensitivity analyses where we censored subjects who did not participate in 
the following surveys. This did not change the pattern of the results.  
 
Persons with previous CVD 
The main results presented in the paper included persons with previous CVD, and 
previous CVD was considered a confounder in the multivariable analyses. Excluding 
persons with previous CVD at baseline might possibly be one way to come closer to 
a causal association. However, this would not represent the general population 
(target population) to whom we want to address the results. Persons with 
hypertension might already have been at risk for CVD for a long time or already 
have suffered from CVD. However, we made sensitivity analyses with the exclusion 
of persons with previous CVD and found the same result pattern.  
 
Reverse causality 
When interpreting the results, a major concern was reverse causality. The question 
was whether the lower activity levels were a result of severe morbidity or higher 
age (both leading to higher mortality). Ageing is associated with higher frequencies 
of comorbidities, higher BP, and lower activity levels 144,145. To exclude the 
possibility of reverse causation, we made two sensitivity analyses. In the first, we 
excluded everyone who had an event during the first three years, assuming that 
persons with severe comorbidities would pass away during the first three years. 
The follow-up time started three years later for the remaining population. In the 
second analysis, we excluded everyone who were older than 60 years of age. In 
both analyses, we found the same pattern of results for both mortality and 
cardiovascular events.  
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Time-to-event analyses with time-dependent covariates 
The study population was followed since 1976, and the covariate data were 
collected longitudinally. Both exposure and other covariates changed over time, 
which is why we selected Cox regression with time-dependent covariate instead of 
using fixed covariates.  
The time-to-event analyses made it possible to let the exposure and 
covariates/confounders change over time.  
 
Persons in medical treatment for hypertension 
Participants who already received pharmacological treatment were included in the 
study population, and they were categorised in stage 1 hypertension, unless their 
BP values justified stage 2 hypertension. In the published paper, we did not add 
sensitivity analyses only for persons already treated with antihypertensive 
medication. These analyses were made later, and the results confirmed a dose-
response pattern between the level of physical activity and mortality with Inactivity 
as reference group: Light activity HR 0.86 [95% CI: 0.78 – 0.96], p=0.005; 
Moderate/high activity HR 0.76 [95% CI: 0.67 – 0.86], p<0.001.  
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Discussion study III 
Study design III: Cross-sectional and cohort study 
Study III consisted of both a cross-sectional study and a cohort study. The 
association between the level of physical activity and LVMi was evaluated in a 
cross-sectional study design. The impact of physical activity on prognosis was 
studied in a cohort study design. The cross-sectional analysis included level of 
physical activity as exposure and LVMi as the outcome.  
 
Assessment of left ventricular mass 
M-mode tracing was the predominant method used to assess LVM in this study. At 
the time of the echocardiographic examination, this method was the standard and 
recommended method to study LVM 146. M-mode assessment is previously shown 
to overestimate LVM 65. Besides, the single dimension image makes it 
representative only in normally ellipsoid shaped ventricles and is less suitable for 
asymmetric distribution of hypertrophy 147. The latter issue remains a limitation in 
2D measurements as well, but 2D measure of LVM facilitates more accurate 
measurements perpendicular to the LV long axis 65.  
Further, we indexed the LVM to body surface area. This measure has previously 
shown to underestimate LVM in overweight and obese hypertensive subjects 148. 
Dividing LVM by height to the allometric power of 1.7 or 2.7 has been suggested to 
minimise this limitation 149.  
In our study population, a total number of N=1,134 persons (37%) were overweight 
(25≤BMI<30), N= 301 (10%) were obese (30≤BMI<35), and N=74 (2%) had severe 
obesity (BMI≥35).  
 
Stratification on sex 
To convey the study results clearly, we chose to analyse the data not stratified on 
sex. A previous publication from the Framingham Heart Study described that men 
had a positive association between level of physical activity and LVM, whereas this 
association was not found for women 150.  Other studies have also found that LV 
remodelling due to physical activity and hypertension is dependent on sex 151–153. 
However, from an epidemiological and physiological point of view, it would have 
been reasonable to stratify on sex, even though we did not find any statistical 
interaction between sex and physical activity on LVMi or outcome. 
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Left ventricular hypertrophy in normal blood pressure 
Interestingly, we found that LVH was present in N=144 persons with normal BP. We 
also found that LVH was associated with significantly higher mortality and 
cardiovascular events in normal BP. It is possible that these persons had masked 
hypertension, which was not discovered at the exam. Presence of LVH could also 
be due to other causes than hypertension, which we did not evaluate in our study 
154,155.  
 
LVH and physical activity as independent predictors of prognosis 
During study III, we made some supplemental analyses, which are not included in 
the published paper. We made a multivariable Cox regression analysis where we 
included both LVH and level of physical activity, beside adjusting for already 
defined confounders (Figure 20). We found that both LVH and level of physical 
activity remained as independent predictors of prognosis; thus, LVH was associated 
with the worsening of the prognosis, while physical activity was associated with a 
better prognosis. These results underscore that LVH has a strong impact on 
prognosis but also that the importance of physical activity remains significant.  
 
Duration of hypertension 
At baseline, the LVMi was significantly higher in persons with hypertension. Only 
N=481 persons were in pharmacological treatment, and the rest N=884 were newly 
diagnosed with hypertension. The fact that their LVMi is higher already at baseline 
might indicate that the newly diagnosed hypertensive subjects have had 
hypertension for a longer time due to the lack of symptoms in essential 
hypertension 100.  
 
Exercise testing 
In recent years, there has been a focus on exercise testing as an important player in 
the risk assessment for hypertension and the development of LVH. The research in 
the field of exercise BP is growing, and the findings in this area are divergent. 
Previous studies have concluded that exaggerated exercise BP is related to the 
future development of hypertension 156 and higher LVM in normotensive persons 
157,158.  
Recently, Tanaka S. and colleagues published a paper describing a study comprising 
143 persons in medical treatment for hypertension. All participants had 
maintenance of the BP<140/90 and did not have LVH on echocardiography at 
baseline 159. During treadmill and cycle ergometer exercise testing, the BP response 
during moderate exercise was measured. After a follow-up time of 2.5 ± 1.6 years, 
they found that the risk of developing LVH was associated with the change in 
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systolic BP during exercise testing; thus the persons who had the highest increase 
in systolic BP during exercise had the highest occurrence of LVH. Controversy exists 
in this field since another study reported by Mizuno R. and colleagues showed that 
exaggerated BP response during exercise was associated with depressed LVH 
regression in hypertensive patients on medical treatment 160.  
  
 Population study of Physical Activity  
79 
 
PERSPECTIVES 
Physical activity, cardiovascular disease, and prognosis 
Studies II and III demonstrated the long-term health benefits of physical activity 
and added more specific knowledge about the importance of exercise in 
hypertension. The role of physical activity as a treatment modality in hypertension 
has been the focus in these studies, and the main conclusions from these studies 
also apply to the especially high-risk sub-groups among hypertensive patients:  
1. persons with LVH, and 
2. patients in stage 2 hypertension.  
Meanwhile, study I went in-depth with the association between physical activity 
and myocardial performance. The results imply that the impact of physical activity 
on cardiac function might be age dependent. However, we should remember that 
not all benefits of physical activity are achieved through changes in cardiac function 
and morphology, and yet, there are many physiological mechanisms in relation to 
physical activity which need to be explored. Longitudinal studies with physical 
activity as an intervention in different age groups and repetitive echocardiograms 
could be a way of exploring the cardiac alterations induced by physical activity.  
 
Future studies 
All three studies give a basis for many future studies. The association between 
physical activity and changes on cardiac morphology and cardiac function has been 
studied extensively in athletes, while we need more studies of this issue in the 
general population who are active on a light-moderate activity level. For this 
population, we also need more studies on different training modalities and the 
impact on myocardial performance.  
The role of physical activity in hypertensive patients with LVH could be supplied 
with echocardiograms during follow-up to explore whether the level of activity was 
associated with changes in LVMi. Further, it would also be interesting to study 
whether the prognosis has a linear association with LVMi among hypertensive 
patients with LVH. 
Another interesting issue is whether physical activity enhances drug-efficacy in 
hypertension. 
Further, the impact of other comorbidities, e.g. how kidney failure at different 
stages affects the prognosis at different levels of LVMi, is also an area for future 
research.  
How to differentiate between physiological and pathological hypertrophy remains 
a clinical challenge. Especially among hypertensive patients at a high activity level, 
we need to clarify when pathological hypertrophy ends and physiological 
hypertrophy starts 161. This also includes further exploration of the diastolic 
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function. Previously, tissue Doppler techniques have been used to explore this 
theme 162,163. 
With the novel echocardiographic methods including 3D echocardiography and the 
development in cardiac magnetic resonance imaging, it will be possible in the 
future to perform studies with more detailed characterisation of cardiac 
morphology and function.  
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CONCLUSIONS 
Study I 
Age modified the association between the level of physical activity and cardiac 
performance. In age <50 years, higher activity levels were associated with better 
myocardial performance. In age > 65 years, higher levels of physical activity were 
associated with worse cardiac function.  
 
Study II 
Higher levels of physical activity were associated with reduction in all-cause 
mortality and cardiovascular events at all levels of BP. This association was present 
in a dose-response pattern for all-cause mortality.  
  
Study III 
Hypertension modified the association between level of physical activity and LVMi. 
In normal BP, higher levels of physical activity were associated with higher LVMi, 
whereas this association was not present in hypertension.   
The presence of LVH did not modify the association between physical activity and 
reduction in mortality/cardiovascular events.  Thus, physical activity was associated 
with reduction in mortality and cardiovascular events, independent of the presence 
of LVH.  
 
 
The following hypothesis was written in the background paper for the Framingham 
Heart Study in 1952: ‘ It is assumed that these diagnoses [hypertensive and 
arteriosclerotic disease] do not each have a single cause (as is the case of most 
infectious diseases), but that they are the result of multiple causes which work 
slowly within the individual. ’ 164–166.  
 
In the present studies, we studied only physical inactivity and hypertension as risk 
factors for cardiovascular disease, both well-described in previous studies. 
However, in the 21st century, we still have many unanswered questions in the field 
of the development and treatment of cardiovascular disease. The role of physical 
activity is just a small part of this.  
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Abstract
This study aimed to test the hypothesis that regular physical activity is associated with improved cardiac function measured 
by tissue Doppler imaging (TDI) in the general population. Within a large prospective community-based population study, 
cardiac function was assessed in 2221 persons by TDI. Longitudinal displacement (LD), early diastolic velocity (e’), and 
myocardial performance index (MPI) was obtained by TDI. Linear univariable and multivariable regression analyses were 
performed in relation to age groups (< 50 years, 50–65 years, > 65 years) and self-reported level of physical activity: I 
(inactivity), II (light activity), III (moderate activity), and IV (high-level activity). Participants < 50 years in the most active 
group had significantly better cardiac performance when compared to all other activity levels (higher levels of e’, LD, and 
lower levels of MPI). The findings remained with statistical significance after adjustment for sex, ischemic heart disease, 
diabetes, hypertension, and body mass index (e’ = 11.0, 95% CI (10.4–11.6), p < 0.001; LD = 12.8 (12.3–13.4), p < 0.003; 
MPI: 0.40 (0.38–0.42), p = 0.02). In age > 65 years, there was a tendency of impaired cardiac function in higher levels of 
exercise. Interaction analysis revealed that age significantly modified the association between physical activity and cardiac 
function (p < 0.001). We found a positive association between higher level of physical activity and improved cardiac function 
in younger persons (< 50 years). In the general population, however, the association interacted with age and amongst persons 
above 65 years there was a negative association between higher level of physical activity and cardiac function.
Keywords Exercise · Cardiac function · Tissue Doppler imaging · Echocardiography · Population study · Cardiac time 
intervals · Physical activity
Abbreviations
BMI  Body mass index
ET  Ejection time
IHD  Ischemic heart disease
IVCT  Isovolumic contraction time
IVRT  Isovolumic relaxation time
LAVI  Left atrial volume index
LD  Longitudinal displacement
LVEF  Left ventricular ejection fraction
MPI  Myocardial performance index
RHR  Resting heart rate
TDI  Tissue Doppler imaging
Introduction
Worldwide, health authorities recommend regular physical 
activity as a means of improving health. This recommenda-
tion is based on multiple studies on the beneficial association 
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between physical activity, mortality, and the development of 
cardiac disease in patients with known heart disease and the 
general population [1–10]. However, a recent publication 
from the Copenhagen City Heart Study has indicated that 
strenuous physical activity is associated with higher mortal-
ity in healthy joggers [11]. Investigations of the association 
between cardiac performance and activity level in the gen-
eral population are sparse.
Tissue Doppler imaging (TDI) provides a comprehensive 
evaluation of systolic and diastolic left ventricular function 
and is superior to conventional echocardiography for risk 
assessment in patients with heart disease and the general 
population [12–16]. Previous investigations have indicated 
that TDI not only identifies deteriorating cardiac function 
in the general asymptomatic population, but also provides 
prognostic information on cardiovascular mortality and mor-
bidity independently of traditional risk factors [14, 17, 18]. 
Moreover, TDI has been used to document improvement 
in systolic and diastolic function following targeted dedi-
cated exercise protocols in healthy individuals as well as in 
patients with cardiovascular risk [19–21]. However, most 
of these studies have included populations of younger age.
Cardiac time intervals are closely related to cardiac 
physiology, hemodynamics, and mechanics. Myocardial 
performance index (MPI), also known as the Tei-index, is 
a method that combines the systolic and diastolic phases of 
the cardiac cycle. MPI is calculated by dividing the sum of 
the isovolumic contraction time (IVCT) and the isovolumic 
relaxation time (IVRT) by the ejection time (ET). In indi-
viduals with impaired cardiac function, IVCT and IVRT are 
prolonged, and ET might be shortened. Thus, MPI is higher 
in individuals with heart disease than in healthy subjects. 
MPI has been reported to be associated with cardiovascu-
lar mortality in patients with heart disease and the general 
population [12, 22, 23].
Using data from the Copenhagen City Heart Study, we 
explored whether higher levels of habitual physical activity 
in the general population are associated with improved car-
diac function assessed by TDI. We chose to focus on the fol-
lowing parameters: e’ (diastolic performance), longitudinal 
displacement (LD, systolic performance), and MPI (com-
bined systolic and diastolic function). Since TDI-parameters 
are highly dependent on age, we decided to study the popu-
lation in the following three age groups: < 50 years, 50–65 
years, and > 65 years.
Methods
Study population
The Copenhagen City Heart Study is a prospective cohort 
study of cardiovascular disease and risk factors among 
Danish citizens. At the first examination in 1976–1978, 
a random sample of citizens from a well-defined area of 
Copenhagen City was invited to participate in the study. 
This present study used data from the fourth examination 
in 2001–2003. The population consisted of persons who 
had been invited to the three previous examinations, and 
a random sample of persons from the younger age group 
(n = 1000). In total, 6237 persons participated. A total of 
2221 randomly selected persons underwent echocardiog-
raphy including TDI. Persons with atrial fibrillation, sig-
nificant valvular stenosis, or regurgitation were excluded 
(n = 157). Due to missing information on physical activ-
ity level, 11 persons were excluded. A total of 2053 per-
sons were included in the current study. All subjects gave 
informed consent to participate, and the study was per-
formed in accordance with the second Helsinki Declaration 
and approved by the regional ethics committee.
Echocardiography
Three experienced echocardiography technicians performed 
all echocardiogram examinations using GE Vingmed Ultra-
sound’s Vivid Five with a 2.5-MHz probe (Horten, Nor-
way). All participants were examined with color TDI and 
two-dimensional and M-mode echocardiography in the left 
lateral decubitus position. All images were recorded with 
second-harmonic imaging at the time of end expiration. 
Collected data were stored on magneto-optical disks on an 
external hard drive (FireWire, LaCie, France) and analyzed 
offline with a commercially available software program 
(EchoPac, GE Medical). The investigator was blinded to 
other information about the participants.
Color tissue Doppler imaging
Color TDI loops were obtained in the apical four-chamber, 
two-chamber, and long-axis views at the highest possible 
frame rate. Myocardial velocities, including e’, were meas-
ured within a 6 mm circular sample volume in the septal, 
lateral, inferior, anterior, posterior, and anteroseptal mitral 
annular positions. Longitudinal displacement (LD) was 
calculated from the area under the velocity curve during 
ejection using an automated algorithm (Fig. 1). TDI curves 
were smoothed by averaging myocardial velocities over 
30 ms. Both LD and e’ were measured in all of the six basal 
segments; the averages were calculated and applied in this 
study.
Previous studies have suggested LD and e’ as being sensi-
tive markers of changes in cardiac function when studying 
the effect of physical activity. We therefore chose to focus 
on LD and e’ in the evaluation of myocardial function in our 
study [19–21].
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The cardiac time intervals were obtained in the api-
cal four-chamber view at the highest possible frame rate. 
A 2–4 cm straight M-mode line was placed through the 
septal half of the mitral leaflet in closed position in end-
systole (Fig. 2). Cardiac time intervals were measured 
based on the color M-mode diagram. The method has 
been described in detail in a previous publication from 
the Copenhagen City Heart Study [24].
Physical activity
All participants filled in the Copenhagen City Heart Study 
Questionnaires containing questions on previous medical 
history, lifestyle, and sociodemographics. The physical 
activity questionnaire included information about activity 
level both at work and during leisure time. The activity level 
was scored from 1 to 4 in the questionnaire with increasing 
activity level (physical activity questionnaire included in the 
Fig. 1  Example of myocar-
dial velocity curve by tissue 
Doppler imaging. The yellow 
circle shows the place where 
the sample is obtained (lateral 
region of the mitral annulus). 
Y-axis: myocardial velocity 
(cm/s). X-axis: time (seconds). 
The positive peak during 
systole is marked by s’ on the 
velocity curve. During diastole, 
early (e’) and late (a’) diastolic 
peak is marked. Mitral annular 
displacement (longitudinal 
displacement) is calculated from 
area under the curve during 
systole (shaded area)
Fig. 2  (Left) Four-chamber 
gray-scale (bottom) and color 
tissue Doppler imaging (top) 
views in end-systole showing 
the position of the M-mode line 
used for measurement of cardiac 
intervals. (Right) Color diagram 
of the tissue Doppler imaging 
M-mode of the anterior mitral 
leaflet. AVC aortic valve clos-
ing, AVO aortic valve opening, 
MVC mitral valve closing, MVO 
mitral valve opening, IVRT iso-
volumic relaxation time, IVCT 
isovolumic contraction time, ET 
ejection time
1252 The International Journal of Cardiovascular Imaging (2019) 35:1249–1258
1 3
electronic supplementary material). Leisure-time physical 
activity levels were defined as follows: Group I—almost 
entirely sedentary, group II—light physical activity for 2 
to 4 h per week, group III—light physical activity for more 
than 4 h per week or more vigorous physical activity for 
2 to 4 h per week, and group IV—high vigorous physical 
activity for more than 4 h per week or regular heavy exercise 
or competitive sports several times per week. According to 
the activity level from the questionnaire, participants were 
divided into four groups: I (inactivity), II (light activity), III 
(moderate activity), and IV (high-level activity).
Statistical analyses
For demographics, Pearson’s Chi square test was used for 
categorical covariates and one-way analysis of variance 
(ANOVA) for continuous covariates. If the data were not 
normally distributed (MPI), transformation to natural loga-
rithm was made, and geometric mean was calculated. The 
Kruskal–Wallis rank test was used instead of ANOVA when 
data were not normally distributed. Linear regression models 
in the following age strata were used to examine the asso-
ciations between activity level and TDI parameters: < 50 
years, 50–65 years and > 65 years. Activity level was consid-
ered as a categorical variable and TDI measurements were 
plotted on a continuous scale. In the multivariable analyses, 
we adjusted for the following pre-specified potential con-
founders: sex, ischemic heart disease, hypertension, body 
mass index (BMI), and diabetes. Since resting heart rate 
(RHR) might affect values of TDI-parameters, we performed 
a separate analysis where we additionally adjusted for RHR 
[25]. Interaction analyses were performed to clarify whether 
interactions between age and physical activity level affected 
the results. The analyses were performed separately for each 
TDI parameter. Linearity, variance homogeneity, and the 
assumption of normality were tested with plots of residuals 
in each age stratum. P-values < 0.05 on two-sided tests were 
considered statistically significant. Values in parentheses are 
95% confidence intervals unless stated otherwise.
All analyses were performed by STATA Statistics/Data 
Analysis version 14.1.
Results
Characteristics of the study population are displayed in 
Tables 1 and 2. BMI was lower in the highest activity groups. 
Frequencies of hypertension, diabetes, and ischemic heart 
disease were lower in higher activity levels. In the highest 
activity groups, we found higher left atrial volume index 
Table 1  Baseline characteristics of study population in relation to level of physical activity
 HR heart rate/ beats per minute, IHD ischemic heart disease, LVEF left ventricular ejection fraction, LAVI left atrial volume index, LD longitu-
dinal displacement, MPI Myocardial Performance Index, MPI = (IVCT + IVRT)/ET, IVCT isovolumic contraction time, IVRT isovolumic relaxa-
tion time. Mean and standard deviations, unless specified otherwise. NS non-significant
The total 
population 
(N = 2053)
Inactivity (N = 180) Light activity 
(N = 1016)
Moderate activity 
(N = 753)
High level activity 
(N = 104)
p-value
Age, years 58.3 ± 16.0 60.6 ± 16.8 60.8 ± 15.5 55.8 ± 15.3 48.0 ± 18.6 < 0.01
Male sex, % 42.7 48.3 37.7 46.1 56.7 < 0.01
Body Mass Index, 
kg/m2
25.5 ± 3.9 26.3 ± 4.4 25.7 ± 4.1 25.0 ± 3.6 24.9 ± 3.2 < 0.01
Resting HR/bpm 67.1 ± 11.3 70.0 ± 10.8 67.6 ± 11.3 66.3 ± 10.9 62.1 ± 12.4 < 0.01
Hypertension, % 43.3 55.3 47.6 36.8 26.9 < 0.01
Diabetes mellitus, % 10.1 11.2 11.2 9.0 3.9 < 0.01
IHD, % 13.9 19.4 16.4 10.2 5.8 < 0.01
Smoking, % < 0.01
 Never smoked 32.4 23.9 31.3 35.2 37.5
 Current smoker 33.4 50.6 35.9 27.0 27.9
 Former smoker 33.5 25.6 32.2 37.5 32.7
LVEF, % 59.7 ± 2.1 59.8 ± 1.1 59.6 ± 2.6 59.8 ± 1.4 60.0 ± 0.4 NS
LAVI, ml/m2 19.3 ± 6.5 17.9 ± 5.5 19.4 ± 7.3 19.3 ± 5.6 21.3 ± 5.8 < 0.01
e’ (cm/s) 7.2 ± 2.7 6.7 ± 2.7 6.8 ± 2.6 7.5 ± 2.6 8.8 ± 3.3 < 0.01
LD (mm) 10.6 ± 2.3 10.4 ± 2.1 10.3 ± 2.2 10.8 ± 2.2 11.6 ± 2.5 < 0.01
MPI (median, in 
parenthesis: 25% 
and 75% percentiles)
0.47 (0.40–0.56) 0.48 (0.43–0.55) 0.48 (0.41–0.56) 0.47 (0.39–0.55) 0.44 (0.39–0.51) < 0.01
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(LAVI), and lower resting heart rate (RHR). Left ventricular 
ejection fraction (LVEF) was similar in all activity groups.
To adjust for confounding concerning age, the population 
was divided into three age strata when we analyzed the tissue 
Doppler parameters: <50 years, 50–65 years, and > 65 years.
Cardiac function and physical activity
Linear regression analysis was performed in each age group 
to clarify whether the level of physical activity was asso-
ciated with myocardial performance. Figures 3, 4, and 5 
illustrate the associations between activity level and cardiac 
function in each age group.
All of the echocardiographic parameters e’, LD, and MPI 
were strongly associated with age, regardless of activity lev-
els. In the following, we describe the associations within 
each age group.
Age < 50 years
In this age group, we found improved systolic and dias-
tolic function with increased activity level. Both LD and 
e’ were significantly higher in high level activity (group 
IV) compared to the three other activity levels. This pat-
tern remained significant after adjusting for sex, diabe-
tes, hypertension, BMI, and ischemic heart disease (e’ 
p < 0.001, LD: p < 0.003, MPI: p = 0.02). Even after Bon-
ferroni correction, activity group IV had a significantly 
higher values of LD and e’. Trend tests were made with 
activity level as a continuous variable. Here, we found that 
activity levels were significantly associated with improved 
cardiac function (higher e’ (p = 0.001), LD (p = 0.004) and 
lower MPI (p < 0.002)). The decrease in MPI was primar-
ily due to a decrease in IVRT/ET (p < 0.001) in higher 
activity levels.
Age 50–65 years
In this age group, we did not find any significant associa-
tion between level of physical activity and systolic or dias-
tolic myocardial performance (e’ p = 0.17; LD: p = 0.16; 
IVRT/ET: p = 0.92; IVCT/ET: p = 0.83; MPI: p = 0.58).
Table 2  Number of persons in 
each age stratum and activity 
group
Age < 50 years Age 50–65 years Age > 65 years In total
I: Inactivity 53 47 80 180
II: Light activity 263 318 435 1016
III: Moderate activity 261 269 223 753
IV: High activity 57 25 22 104
In total 634 659 760 2053
Fig. 3  Early diastolic velocity 
e’ in relation to age group and 
activity level. Mean and 95% 
confidence intervals
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Age > 65 years
In age > 65 years, both systolic and diastolic myocardial 
function seemed to be similar in all four activity levels 
when activity levels were analyzed as a categorical varia-
ble. The trend test (activity levels as a continuous variable) 
revealed a significant tendency towards reduced myocar-
dial function with increased activity level independent of 
sex, ischemic heart disease, hypertension, BMI, and dia-
betes (an increase of MPI by 0.02 (0.006–0.038) for each 
higher activity level, p < 0.01). No significant changes in 
e’ and LD were found (e’: p = 0.402; LD: p = 0.452).
Fig. 4  Longitudinal displace-
ment (LD) in relation to age 
group and activity level. Mean 
and 95% confidence intervals
Fig. 5  MPI (geometric mean 
and 95% confidence inter-
vals) in relation to age group 
and activity level. MPI= 
(IVRT + IVCT)/ET. MPI 
myocardial performance index, 
IVRT isovolumic relaxation 
time, IVCT isovolumic contrac-
tion time, ET ejection time. 
*The p-values in trend analysis 
for MPI within each age group
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Adjustment for RHR
We performed separate analyses where we additionally 
adjusted for RHR. Adjusting for RHR did not change any 
of the results.
Interaction analyses
Interaction analyses with adjustment for potential confound-
ers revealed interaction between age group and activity level 
when studying e’ (p < 0.008). This means that the associa-
tion between cardiac function and activity level is changed 
by aging; physical activity in young age was associated with 
higher levels of e’ compared with the older age groups. For 
LD, we did not find any significant interaction (p = 0.182).
Interaction analyses revealed a significant interac-
tion between activity level and age when studying MPI 
(p < 0.001).
Resting heart rate and level of physical 
activity
We studied the RHR in relation to age group and level of 
physical activity (Fig. 6). There was a tendency towards a 
lowering of the RHR in higher activity levels when study-
ing age groups < 50 years, and 50–65 years. For individuals 
aged < 50 years, we found a drop in heart rate of 2.4 beats/
min (95% CI 0.7–3.6) for each increased level of activity 
(p < 0.001). A decrease of 2.0 beats/min (95% CI 0.7–3.4) 
was found for trend analysis in persons aged 50–65 years 
(p < 0.01). Both findings were statistically significant. For 
persons aged > 65 years, we did not find any association 
between the level of physical activity and the heart rate 
(p = 0.39).
Discussion
This large community-based study investigated the associa-
tion between cardiac function and level of physical activity. 
To the best of our knowledge, this is the first study to exam-
ine this association in relation to age. Our results indicate 
that a better myocardial performance in relation to higher 
levels of physical activity is achieved only when age is below 
50 years. In age > 65 years, there seems to be a tendency for 
impairment of myocardial performance at higher activity 
levels.
The parameter e’ is a sensitive and frequently used echo-
cardiographic measure in studies on the diastolic function 
in relation to physical activity including sports [20, 26–28]. 
Moreover, e’ has been shown to be significantly higher in 
endurance and strength athletes. LD is associated with stroke 
volume and ejection fraction [29–31]. The studies includ-
ing LD as a measure of systolic function found significant 
changes in relation to physical activity [19, 20].
Studies of the athlete’s heart have revealed structural and 
functional changes towards higher systolic and diastolic 
performance assessed by TDI when compared with age-
matched non-athletes [26–28]. Usually, athletes belong to 
a young age group. Our results support these findings; thus 
we also find a high level of physical activity to be associated 
Fig. 6  Resting heart rate (RHR, 
beats per minute) in relation to 
age group and activity level. 
*The p-values in trend analysis 
for RHR within each age group
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with improvement in myocardial performance in the younger 
age group.
Andersen et al. described improved systolic and diastolic 
myocardial function in sedentary women less than 50 years 
of age (36.5 ± 8.2 years) undergoing 16 weeks of regular 
physical training [20]. These findings suggest that cardiac 
adaptations are easily achieved in the younger age group. 
However, changes in cardiac function in older age groups 
in relation to physical activity require further investigation.
A few studies have investigated the association between 
cardiac time intervals and the level of physical activity. In 
1999, Libonati et al. described how systolic time intervals 
were prolonged and isovolumic relaxation time shortened 
in long-distance runners in comparison to short-distance 
runners [32]. They also found lower levels of MPI in long-
distance runners. Seismocardiography was used to deter-
mine the cardiac time intervals, which is different from the 
method we used in our study. Despite differences in the 
study population, our study confirms the findings by Libo-
nati et al.
From a physiological point of view, it is reasonable to 
assume that a younger heart might be more sensitive to 
changes in myocardial performance in relation to exercise. 
One of the reasons could be that this age group has a low 
frequency of medical conditions that affect cardiac function 
such as hypertension, diabetes, and IHD. In addition, aging 
is associated with molecular and cellular alterations includ-
ing increased interstitial myocardial fibrosis [33–35]. These 
changes cause altered myocyte contractile function, stiffness 
of the myocardium, and thus impairment of systolic as well 
as diastolic function in the aging population.
The interaction analyses in our study show that age might 
be an effect modifier when studying the association between 
physical activity and myocardial performance. These find-
ings emphasize the importance of age when studying cardiac 
adaptations in relation to physical activity. Effect modifica-
tion in this context means that younger age groups have a 
greater impact on improving cardiac function when exercis-
ing. In age groups < 50 years and 50–65 years, the resting 
heart rate decreased in higher levels of activity, whereas 
the heart rate was unchanged in those aged > 65 years. A 
decrease in resting heart rate during physical activity is a 
basic physiological change. In our study population, this 
correlation was seen only in those aged < 65 years. This is 
in line with the findings by TDI, revealing that improved 
myocardial performance was associated with increasing 
levels of activity in age groups < 65 years, but not in those 
aged > 65 years.
Our results raise the question of whether myocardial per-
formance is reversed by aging regardless of exercise. There 
may be a cut-off point in age, a “point of no return,” where 
the beneficial effects of physical activity on myocardial per-
formance might no longer exist.
One of the limitations of our study is that we do not have 
data for how many years the participants have had the reported 
physical activity level, and whether their activity level changed 
during their lifetime. We assume that the reported activity level 
has been the most dominant level during their adult lifetime. 
Thus, we assume that the participants in the two highest age 
groups have had a high level of physical activity for many 
years, if reported as such.
In defining the groups according to their level of activity, 
we primarily focused on the self-reported activity level in lei-
sure time. In 792 persons, we did not have data on their activ-
ity level during working hours, so the analyses could not be 
performed with classification of activity levels at work only.
However, in this study, physical activity was not an inter-
vention, and the results reflect associations, and no causal 
inference can be assessed. Previous studies on physical exer-
cise as an intervention reported improvement in cardiac func-
tion measured by TDI. More studies of this kind are needed, 
especially studies including persons > 50 years of age.
Previous studies comparing aerobic interval training with 
continuous endurance training found better myocardial per-
formance after interval training [20]. How aging affects this 
association thus requires further exploration.
The current recommendations concerning regular physi-
cal activity do not distinguish between differences in age. 
Even though several studies have shown a reduction in cardi-
ovascular disease and mortality in those who are physically 
active, the effects on myocardial performance are sparsely 
studied. It is scientifically interesting whether a reduction 
in mortality and cardiovascular disease in relation to physi-
cal activity in the general population is associated with 
improved myocardial performance. Schnohr et al. found that 
long-term moderate or high levels of physical activity were 
associated with significantly lower all-cause mortality and 
death from coronary heart disease in an observational study 
design [4]. Physical activity induces physiological benefits 
such as increased insulin sensitivity, lower blood pressure, 
and improved lipid profile, which could partly explain these 
findings. However, persons capable of participating in mod-
erate to high levels of physical activity have good physical 
health, so the increased survival time for these individu-
als might therefore be explained by factors other than only 
physical activity.
Our study results reveal that aging could reverse the ben-
efits of physical activity on cardiac function. These findings 
need to be confirmed in future studies.
Conclusion
In the general population, the association between 
increased levels of physical activity and improved car-
diac function, assessed by TDI, was found only in 
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persons < 50 years of age. In persons aged > 65 years, 
higher levels of physical activity were associated with 
reduced myocardial performance. Our results suggest 
that the beneficial associations between myocardial per-
formance and physical activity are altered and reversed 
by aging. Myocardial performance measured by TDI 
decreases with age, independent of the level of physical 
activity. Additional studies are needed to explore more 
associations between physical activity and myocardial per-
formance in relation to age and exercise modalities and 
training protocols.
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A. The physical activity questionnaire 
Information on activity level at work as well as in leisure time was included. The activity level was 
scored from 1 to 4 in the questionnaire with increasing activity level. 
Question 1  
Please indicate your PHYSICAL ACTIVITY LEVEL DURING WORK over the last year 
(students, home-makers and the unemployed should fill out the answers while retirees without work 
should proceed to question 2) (choose one option only) 
 
 
2 
 
I Primarily seated while working  
e.g. deskwork, home-maker with no children and with 
domestic help                        
 
II Sitting or standing, sometimes walking 
e.g. clerk, teacher, home-maker washing and cleaning 
without small children                                                                               
 
III Walking, lifting once in a while 
e.g. postal worker, caretaker, home-maker washing and 
cleaning with one or more small children   
 
IV Heavy physical work   
e.g. construction worker, furniture remover 
 
 
 
 
 
If options III or IV were chosen. Do you often lift heavy weights?                      YES ____ NO ____ 
 
 
 
 
 
 
 
 
Question 2  
Please indicate your PHYSICAL ACTIVITY LEVEL IN YOUR SPARE TIME (including 
transportation to and from work) over the last year (choose one option only) 
 
 
I Almost completely physically passive or physically 
active for less than 2 hours per week 
e.g. reading, watching TV, going to the cinema 
 
 
II Light physically activity 2-4 hours per week                     
e.g. walking, cycling, light garden work or low-intensity 
workouts 
                                                                         
3 
 
III Light physical activity more than 4 hours per week or 
more strenuous activity 2-4 hours per week 
e.g. fast walking and/or fast cycling, heavy garden work, 
high-intensity workouts involving getting sweaty and 
short of breath                                                                                                                                
 
IV More strenuous physical activity for more than 4 hours 
per week or regular high-intensity workouts or sporting 
competitions several times per week 
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Hypertension kills 9.4 million people annually worldwide—about as many as all infectious diseases combined.1 The 
World Health Organization has declared hypertension to be the 
leading risk factor for global death in rich as well as developing 
countries bringing it to be a major public health problem.2–4 Its 
prevalence has an epidemic growth, and the disastrous conse-
quences are well described.3–9 The warning of the upcoming 
magnificent burden of disease and death worldwide is calling 
for public health interventions with low healthcare cost.
Elevated blood pressure (BP) is modifiable by non-phar-
macological interventions such as regular physical activity.10–12
We know from previous epidemiological studies that reg-
ular physical activity is associated with lower mortality in the 
general population.13,14 Intervention studies in patients with 
hypertension have granted us the knowledge on how reg-
ular physical activity resulted in a significant reduction in BP 
values.10,15–18
However, there is a missing link and lack of evidence in 
the association between BP-reducing effect of regular exercise 
and the assumption on this association being directly correlated 
with reduced mortality and cardiovascular disease (CVD).
Besides, it has been a great challenge to verify the dose of 
exercise that will produce maximum health benefits at differ-
ent levels of hypertension.
The aim of this study was
1. To test the hypothesis that daily physical activity is as-
sociated with mortality and cardiovascular outcome in 
persons with hypertension
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Abstract—It has been a challenge to verify the dose of exercise that will produce the maximum health benefits in hypertension. 
This study aimed to explore the association between level of daily physical activity, all-cause mortality and cardiovascular 
outcome at different blood pressure levels. A random sample of 18 974 white men and women aged 20 to 98 years were 
examined in a prospective cardiovascular population study. Self-reported activity level in leisure-time was drawn from 
the Physical Activity Questionnaire (level I: inactivity; II: light activity; and III: moderate/high-level activity). Blood 
pressure was defined as normal blood pressure: <120/<80 mm Hg; Prehypertension: 120–139/80–89 mm Hg; Stage I 
hypertension: 140–159/90–99 mm Hg; Stage II hypertension ≥160/≥100 mm Hg. The mean follow-up time was 23.4±11.7 
years. At all levels of blood pressure, higher levels of physical activity were associated with lower all-cause mortality in 
a dose-response pattern. The pattern remained unchanged after adjustment for following confounders: sex, age, smoking 
status, education, diabetes mellitus, previous cardiovascular disease, body mass index, and calendar time. Compared 
with inactivity, following hazard ratios were found for stage I hypertension: light activity, hazard ratio 0.78 (0.72–0.84; 
P<0.001), moderate/high-level activity, hazard ratio 0.69 (0.63–0.75; P<0.001). At all levels of blood pressure, the risk of 
cardiovascular events was significantly reduced independent of the level of physical activity. In conclusion, the association 
between physical activity and all-cause mortality was present in an inverse dose-response pattern at all levels of blood 
pressure. Physical activity was associated with reduction in cardiovascular events independent of the level of physical 
activity.  (Hypertension. 2019;74:1307-1315. DOI: 10.1161/HYPERTENSIONAHA.119.13786.) 
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2. To investigate whether this association is present in a 
dose-response pattern
Methods
Data Availability
This study used data based on human persons. The data used in this 
study are governed by the Danish Data Protection Agency. Any addi-
tional researcher who wants access to these data is required to file a 
formal application to the Danish Data Protection Agency. Therefore, 
the authors cannot grant access to the data used in this study.
Study Population
The Copenhagen City Heart Study is a longitudinal cardiovascular 
population study initiated in 1976. A random sample of 19 329 white 
men and women aged 20 to 98 years was drawn from the Danish 
civil registration system as of 1 January 1976. The sample was strat-
ified by age and sex (5-year age strata from the age of 20 years). 
A total number of 14 223 participated in the first examination. 
The population sample went through 4 examinations (1976–1978, 
1981–1983, 1991–1994, and 2001–2003). All subjects from the orig-
inal sample were invited to all subsequent examinations, and a new 
random sample of men and women was included each time. The in-
clusion criteria were age ≥20 years. There were no exclusion crite-
ria. To the first examination in 1976–1978, in total 19 329 persons 
were invited and 73.6 % (N=14 223) of them participated.19 For the 
subsequent examinations, the response rates were: second examina-
tion (1981–1983): 12 698/18 089 (70.2%); third examination (1991–
1994): 10 135/16 560 (61.2 %); fourth examination (2001–2003): 
6237/12 599 (49.5%).
In total, 18 974 persons were included in the current study and fol-
lowed until the outcome of interest or April 2018. Only 214 persons 
were lost to follow-up due to emigration.
The study was approved by the Committee of Biomedical 
Research Ethics for the Capital Region in Denmark. All participants 
gave written, informed consent, and the study was performed in ac-
cordance with the second Helsinki Declaration.
Survey Methods
Established procedures and examinations for cardiovascular epidemi-
ologic surveys were used (Rose & Blackburn).20 A self-administered 
questionnaire concerning previous medical history, cardiovascular 
risk factors, socio-economic status (income, education, marital 
status), medication, and family history was completed and checked 
by the staff. All participants also fulfilled a questionnaire including 
questions on physical activity at work and in leisure-time.
Physical Activity Questionnaire
The same self-administered physical activity questionnaire was 
used in all 4 examinations. A single question with 4 categories was 
applied for measuring leisure-time physical activity: ”Which descrip-
tion most precisely covers your pattern of physical activity during 
leisure-time?”
1. Inactivity. Being almost entirely sedentary (eg, reading, watch-
ing television or movies, engaging in light physical activity such 
as walking or biking for less than 2 h/wk). (Intensity: <3 meta-
bolic equivalents (METs), used as reference group; Score 1
2. Light activity. Engaging in light physical activity for 2 to 4 h/
wk. (Intensity: 3–4.5 METs; Score 2)
3. Moderate activity. Engaging in light physical activity for more 
than 4 h/wk or more vigorous activity for 2 to 4 h/wk (eg, brisk 
walking, fast biking, heavy gardening, sports that cause perspi-
ration, or exhaustion). (Intensity: 4.5–6 METs; Score 3)
4.  High-level activity. Engaging in highly vigorous physical activity 
for more than 4 h/wk or regular heavy exercise or competitive 
sports several times per week. (Intensity: >6 METs; Score 4]
Because of very few persons (n=570) in the highest category of 
leisure-time physical activity (score 4), the variable was categorized 
into: score 1= Inactivity, score 2= Light activity, and score 3 to 4= 
Moderate/high level activity.
Clinical Examination
Clinical examination included the measure of BP, lung function, 
height, weight, resting heart rate, electrocardiogram, and blood 
samples.
BP Measurements
The World Health Organization guidelines recommended by 
Rose & Blackburn were followed in all 4 surveys.20 The rec-
ommendation suggested that epidemiologists measure BP 
once under highly standardized circumstances. The result is 
called a casual BP and is adopted by several epidemiological 
studies. Casual BP is shown to predict hypertension and cardi-
ovascular disease very well.21,22
The subject was seated in a comfortable chair designed for 
BP measurements. The back was comfortably supported, and 
the arm was supported with the antecubital fossa at heart level. 
BP was measured once on the non-dominant arm after a min-
imum 5 minutes rest with the subject in the sitting position. 
A cuff was applied evenly to the upper arm. The size of the 
inflatable part of the BP cuff was 12×22 cm in survey 1, 12×26 
cm in surveys 2, 3, and 4. For subjects with an upper arm cir-
cumference >46 cm, a cuff measuring 15×37 cm was used. 
Specially trained technicians using a standardized method and 
a London School of Hygiene Sphygmomanometer performed 
the measurements. The London School of Hygiene is a blind, 
mercury-in-glass Sphygmomanometer designed to reduce ob-
server bias. The fall of the mercury column was set to 2 mm/s. 
The Korotkoff sounds were auscultated through a stethoscope 
placed over the brachial artery. Systolic BP was defined as 
the pressure at which the sounds were first heard. The fifth 
Korotkoff sound (the sounds disappear) defined the diastolic 
BP. The measurement of BP was performed once. In all 4 sur-
veys, the technicians were instructed in the same way, and all 
conditions during the measurements were identical in the 4 
surveys. All equipment was examined at regular intervals.
The BP-levels were defined as following23: 
1. Normal BP: systolic BP <120 mm Hg and diastolic BP 
<80 mm Hg
2. Prehypertension: systolic BP between 120 and 139 
mm Hg or diastolic BP between 80 and 89 mm Hg
3. Stage I hypertension: systolic BP between 140 and 159 
mm Hg or diastolic BP between 90 and 99 mm Hg or 
receiving pharmacological treatment for hypertension 
with systolic BP <160 mm Hg/diastolic BP <100 mm Hg
4. Stage II hypertension: systolic BP ≥160 mm Hg or dias-
tolic BP ≥100 mm Hg
Potential Confounders
Potentially confounding factors for the association between leisure-
time physical activity and outcomes were defined as following: sex, 
age, smoking status (never smoker, former smoker, 1–14 g tobacco 
per day, ≥15 g tobacco per day), education, diabetes mellitus, pre-
vious CVD, class of body mass index (BMI; underweight [BMI, 
<18.5 kg/m2], normal weight [BMI, 18.5–24.9 kg/m2], overweight 
[BMI, 25.0–29.9 kg/m2], severe overweight [BMI ≥30.0 kg/m2]), and 
calendar time.
Follow-Up and Outcome
Subjects were followed in the Danish national registers from the date 
of their first examination until 19 April 2018 or death.
Data on hospital admission, date of death, and death cause were 
drawn from the Danish National Patient Register24,25 and the Danish 
Register of Causes of Death.26 In Denmark, every person has a unique 
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identification number which is linked to the Danish registers.27 By 
this identification number, it is possible to gather information on ex-
act dates and diagnoses for all citizens’ hospital contacts, death date, 
and death causes.
1. Primary end point: all-cause mortality.
2. Secondary end point: cardiovascular events defined as 
admission for acute myocardial infarction, heart failure, 
or stroke, or death of the same causes.
Statistical Analysis
For demographics, Pearson’s χ2 test was used to compare categorical 
variables and one-way analysis of variance to compare continuous 
variables between physical activity groups.
Mortality rates and rates for cardiovascular events were calcu-
lated as the number of events/100 person-years. The associations be-
tween physical activity, all-cause mortality, and cardiovascular events 
were assessed using Cox proportional hazards regression analyses 
with time-dependent covariates. Associations were investigated with 
stratification according to the BP categories. The Cox models were 
performed with age as the underlying time scale and age at baseline 
as the entry time. All adjusted models included the following addi-
tional covariates: sex, smoking status (never smoker, former smoker, 
1–14 g tobacco per day, ≥15 g tobacco per day), education, diabetes 
mellitus, previous CVD, BMI-class, and calendar time. The covari-
ates were revised each time an individual participated in a new ex-
amination. The subjects were censored at emigration or the end of 
follow-up. None of them was lost to follow-up. If a participant did not 
participate in a subsequent examination, the covariates were revised 
the next time the person was examined using the last observation car-
ried forward principle.
Competing Risk
Cardiovascular events (admission for acute myocardial infarction, 
heart failure, stroke, or death of the same causes) were assessed using 
Cox proportional hazards. Death from other causes was considered 
a competing risk. We also assessed the same outcomes by Fine and 
Gray’s subdistributional hazards model with death from other causes 
as a competing risk.
Sensitivity Analyses
Sensitivity analyses were performed to investigate whether censoring 
at the time of absence from one or more examinations at the subse-
quent surveys changed the results. Further, sensitivity analyses were 
also made to explore whether excluding persons with previous CVD 
changed the results.
To clarify whether reverse causality could confound the results, 
we made 2 additional sensitivity analyses: in the first one, we ex-
cluded everyone who had an event during the first 3 years after in-
clusion in the study and let the follow-up time start 3 years later for 
the remaining study population. In the second analysis, we excluded 
everyone aged >60 years.
Interaction Analyses
We tested whether physical activity modified the prognostic value of 
BP for both all-cause mortality and cardiovascular events. Interaction 
analyses were also performed to explore whether sex modified the 
association between activity level and mortality. To clarify if being 
young had different effect on the association between physical ac-
tivity and mortality, we divided the population into 2 age-groups (≤60 
years and >60 years) and assessed if the age groups induced effect 
modification.
Results
Individuals in the inactive group had higher systolic BP, dias-
tolic BP, resting heart rate, and BMI. We also found a higher 
frequency of diabetes mellitus and hypertension in this group.
Table illustrates the population characteristics for the par-
ticipants at their first examination. The mean follow-up time 
was 23.4±11.7 years. A total of 214 persons (1.1%) were lost 
to follow-up due to emigration and were censored at the date 
of emigration.
All-Cause Mortality
During the follow-up, 13 355 persons died. In all BP groups, 
the level of physical activity was associated with lower mor-
tality in a dose-response pattern. Both the mortality rates and 
Cox regression analyses showed the same pattern (Figures 1 
and 2). The results remained highly statistically significant 
after adjustment for confounders. There was no interaction 
between activity level and BP-level on all-cause mortality 
(hazard ratio [HR], 1.00 [95% CI, 0.98–1.04], P=0.68). This 
means that physical activity had the same effect on mortality 
in all levels of BP. There was no effect modification of sex on 
the association between physical activity level and mortality 
except for prehypertension (HR, 0.88 [95% CI, 0.79–0.98], 
P=0.02). Being in young (≤60 years) versus older age group 
did not modify the association between activity level and mor-
tality in any of the BP-levels (eg, for stage 1 hypertension: 
HR, 1.07 [95% CI, 0.97–0.18], P=0.17).
Cardiovascular Events
The number of cardiovascular events was 9470. This number 
included 1198 persons who had acute myocardial infarction, 
heart failure, or stroke and 8272 persons who died of one of 
these causes. Any level of activity was, compared with inac-
tivity, associated with reduced cardiovascular events, as il-
lustrated in Figures 3 and 4. Both mortality rates (Figure 3) 
and Cox regression with time-dependent covariates (Figure 4) 
showed this pattern. Competing risk analyses with Fine and 
Gray’ subdistribution hazards model showed the same pattern 
(Figure 5). There was no interaction between activity level 
and BP-level on cardiovascular events (HR, 1.01 [95% CI, 
0.97–1.05], P=0.62).
Persons with BP >180/110 mm Hg
Persons with BP >180/110 mm Hg are usually not encouraged 
to perform regular exercise.28 We, therefore, assessed both all-
cause mortality and cardiovascular outcome particularly in this 
group. We found, that the result pattern remained unchanged 
for both outcomes. For all-cause mortality, following hazard 
ratios were found: Inactivity HR=1 (reference); light activity, 
0.93 [0.82–1.07], P=0.32; moderate/high level activity, 0.82 
[0.71–0.96], P=0.02. For cardiovascular events: light activity 
0.81 [0.69–0.94], P=0.006; moderate/high level activity, 0.80 
[0.67–0.95], P=0.01.
Sensitivity Analyses
Sensitivity analyses were performed to investigate whether 
censoring the participants who had an absence from one or 
more of the subsequent surveys would have changed the 
results. These persons were censored at the time of the sub-
sequent survey they did not attend. The same univariable and 
multivariable analyses were performed with censoring at the 
time of absence. The results did not change pattern compared 
with the results without censoring at the time of absence. We 
performed the same statistical analyses with exclusion of per-
sons with previous CVD, so the cohort consisted only of per-
sons without known cardiac disease. The results for all-cause 
mortality and cardiovascular outcome remained the same.
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We also made sensitivity analyses to clarify whether re-
verse causality could explain the results. In the first analyses, 
we excluded all who had an event <3 years after inclusion in 
the study and let the follow-up time start 3 years later for those 
remained in the study population. In the second analyses, we 
excluded all who were aged >60 years. In both analyses, the 
pattern of results was unchanged for both all-cause mortality 
and cardiovascular events.
Discussion
To date, this is the first study to show long-term associa-
tions between daily levels of leisure-time physical activity, 
Table. Population Characteristics for the Participants in Relation to the 3 Activity Levels at Their First Examination
Characteristics Inactivity, N=3483 Light Activity, N=9692
Moderate/High Level Activity, 
N=5715 P Value
Age at examination, y 54.4±12.7 51.1±12.8 47.0±14.4 P<0.001
Male sex, No. (%) 1628 (46.7) 4025 (41.5) 3123 (54.6) P<0.001
Treated with antihypertensive, No. (%) 307 (8.9) 613 (6.3) 243 (4.3) P<0.001
Diabetes mellitus, No. (%) 151 (4.6) 260 (2.8) 114 (2.1) P<0.001
Systolic blood pressure, mm Hg 139±23 136±22 133±21 P<0.001
Diastolic blood pressure, mm Hg 84±13 82±13 81±13 NS*
Body mass index, kg/m2 25.8±4.8 25.0±4.1 24.5±3.7 P<0.001
Previous CVD,† No. (%) 196 (5.6) 291 (3.0) 163 (2.9) P<0.001
Smoking, No. (%) P<0.001
  Never smoked 613 (17.7) 2085 (21.6) 1446 (25.4)
  1–14 g tobacco/d 849 (24.5) 2611 (27.0) 1462 (25.7)
  >14 g tobacco/d 1509 (43.6) 3278 (34.0) 1725 (30.3)
  Former smoker 494 (14.3) 1682 (17.4) 1054 (18.5)
Resting heart rate, bpm 76±14 74±13 71±13 P<0.001
Cholesterol, mmol/L 6.1±1.3 6.0±1.3 5.7±1.3 NS
Cardiac medication, No. (%) 184 (5.3) 289 (3.0) 119 (2.1) P<0.001
Education, No. (%) P<0.001
  <8 y 1945 (56.1) 3956 (40.9) 1865 (32.7)
  8–10 y 1075 (31.0) 3684 (38.1) 1957 (34.3)
  ≥11 y 447 (13.0) 2042 (21.1) 1882 (33.0)
Mean and standard deviation, unless specified otherwise. 
*NS indicates non-significant.
†CVD indicates cardiovascular disease.
Figure 1. All-cause mortality. Mortality rates 
(no. of deaths/100 person-years) for all-cause 
mortality in relation to activity level and blood 
pressure (BP) level. In the table below: No. of 
observations, and in parenthesis, no. of events 
is given.
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all-cause-mortality, and cardiovascular outcome in all levels 
of BP in the general population. This study addresses many 
unanswered questions and has 3 main findings. First, higher 
levels of physical activity were inversely associated with all-
cause mortality at all levels of BP. Second, this finding was 
dose-dependent regardless of BP-level. Third, cardiovascular 
outcome (admissions for acute myocardial infarction, heart 
failure, stroke, or death of same causes) was significantly 
reduced by physical activity independent of the BP-level. For 
both all-cause mortality and cardiovascular events, most of the 
health benefits are achieved already at the light activity level 
which was related to significant reduction in outcome com-
pared with inactivity.
We did not find any interaction between the level of 
physical activity and BP groups. This means that the lev-
els of physical activity have the same effect on outcome in-
dependent of the level of BP. Thus, recommendations on 
physical activity should not be modified by the level of BP 
but should be the same in all BP-levels to achieve maximum 
health benefits.
Further, the association between physical activity and out-
come in stage 2 hypertension (BP >160/100 mm Hg) is the 
same as in the other BP groups. This is an important finding, 
since many clinicians usually have precautions in recommend-
ing physical activity in patients with stage 2 hypertension. 
According to the European Society of Cardiology/European 
Society of Hypertension guidelines 2018, physical activity is 
not recommended in persons with BP >180/110 mm Hg.28 Our 
results do not imply any dangerous effect of exercise in this 
patient group; the highest level of physical activity in stage 2 
hypertension is also associated with lower mortality and car-
diovascular outcome compared with both inactivity and light 
activity. The additional analysis we made in only persons with 
BP >180/110 confirmed this conclusion.
Figure 2. All-cause mortality. Cox regression with time-dependent covariates showing hazard ratios and 95% CIs for all-cause mortality for each of the blood 
pressure levels according to the level of physical activity. Left, Age-adjusted analysis. Right, After adjustment for sex, age, calendar time, smoking status, 
BMI-class, diabetes mellitus, previous cardiovascular disease, and education. *P<0.05; **P<0.01; and ***P<0.001.
Figure 3. Cardiovascular events. Event 
rates (no. of events/100 person-years) for 
cardiovascular events in relation to activity level 
and blood pressure (BP) level. Cardiovascular 
events are defined as admissions due to acute 
myocardial infarction, heart failure, stroke, or 
death of one of the causes. In the table below: 
No. of observations, and in parenthesis, no. of 
events is given.
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An important point is, that majority of the health benefits 
is achieved by light activity, which is an activity level most 
persons can perform. For persons at inactivity level, this might 
be a unique motivation to increase their activity level slightly.
This study has several strengths. The study population en-
compass a randomly selected large sample from the general 
population, and only a limited number of participants (n=214) 
were lost to follow-up. We had detailed information on the po-
tential confounding variables. The long follow-up time and 
complete follow-up data from the Danish National Patient reg-
isters made it possible to measure specific outcome and event 
dates. Cox regression with time-dependent covariates made 
it possible to incorporate updated covariate values, including 
information from health examinations, activity levels, medical 
history, and changes in confounders for each of the individuals. 
The sensitivity analyses excluded reverse cause causality as a 
possible explanation for the associations found in this study.
The physical activity questionnaire used in this study is 
well-established, described by Rose & Blackburn, and has 
been shown to discriminate between sedentary persons and 
more active counterparts concerning maximal oxygen up-
take.20 According to the METs calculation due to the activity 
levels presented in the questionnaire, all activities having more 
than 3 METs effort daily is advantageous for reducing CVD 
and mortality. The new guidelines from European Society of 
Cardiology/European Society of Hypertension  recommend 
Figure 4. Cardiovascular events. Cox regression with time-dependent covariates showing hazard ratios and 95% CIs for cardiovascular events for each 
of the blood pressure levels according to the level of physical activity. Left, Age-adjusted analysis. Right, After adjustment for sex, age, calendar time, 
smoking status, BMI-class, diabetes mellitus, previous cardiovascular disease, and education. Cardiovascular events are defined as admissions due to acute 
myocardial infarction, heart failure, stroke, or death of one of the causes. Death from other causes was considered as a competing event. *P<0.05; **P<0.01; 
and ***P<0.001.
Figure 5. Cardiovascular events. Cardiovascular events assessed by Fine and Gray subdistributional hazard. Left, age-adjusted analyses. Right, adjusted for 
age, sex, calendar time, smoking status, BMI-class, diabetes mellitus, previous cardiovascular disease, and education. Cardiovascular events are defined as 
admissions due to acute myocardial infarction, heart failure, stroke, or death of one of the causes. Death from other causes was considered as a competing 
event. SHR indicates subdistributional hazard ratio. *P<0.05; **P<0.01; and ***P<0.001.
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30 minutes activity 5 to 7 d/wk for persons with hyperten-
sion.28 The recommended level matches with the light activity 
level in our study.
What Is Already Known?
Although it is well-established that regular physical activity 
has a BP-reducing effect and well-known that physical ac-
tivity is associated with better survival, reports on long-term 
outcome in hypertension due to a habitual level of physical 
activity are scarce.
We performed a systematic literature search in Embase 
and Medline for the period January, 1985 to October, 2018. 
We found some studies that aimed to investigate the associa-
tion between physical activity and outcome in hypertension in 
other settings than ours.
A Swedish study by Engström et al followed 642 per-
sons with hypertension for 25 years. Perhaps due to the lim-
ited number of persons, they chose to include both inactivity 
and light activity in the reference group (non-vigorous) and 
measured the CVD death compared with the vigorous activity 
group. They had a somewhat peculiar finding that hyperten-
sive physically active persons had lower CVD mortality than 
normotensive non-active persons, which is not consistent with 
several previous studies investigating the association between 
leisure-time physical activity and long-term outcome in the 
general population.29,30 They explain it by the fact of exclusion 
of persons with symptomatic atherosclerotic disease, different 
smoking habits, and lipid levels in the study population.
Vatten et al31 studied a population consisting of 4766 per-
sons who had never used BP medication and without a history 
of CVD. The cohort was examined once. In the analyses, the 
systolic and diastolic BP were categorized into 7 categories. 
Their results support our findings since they found higher rel-
ative risk in higher BP and lower activity level. However, their 
statistical analyses were based on relative risk, which is a cu-
mulative risk rate at the time-point at the end of follow-up and 
does not consider the time to each of the events.
Sui et al32 also published an interesting study about the as-
sociation between fitness level and outcome in hypertension. 
One of the strengths in their study was that cardiorespiratory 
fitness was measured by treadmill exercise test. However, 
their measure of outcome was based on self-reported mail-
back surveys, which might be less robust for measuring hard 
end point outcomes.
Another relevant study originating from Scandinavia in-
cluded only hypertensive individuals and found that physical 
activity reduced cardiovascular mortality. The study, which 
was performed by Hu et al,33 had several strengths, among 
others a long follow-up time of 19.9 years. One of the limita-
tions in their study was that they did not have data on changes 
in physical activity, BP, or other covariates during follow-up. 
Also, they included only hypertensive persons without a pre-
vious history of CVD and diabetes mellitus, which may not 
represent the usual population cohort of persons with hyper-
tension in the general community.
Fang et al34 also found protective effects of physical ac-
tivity in hypertensive subjects but could not show the same as-
sociation among normotensive and pre-hypertensive subjects, 
perhaps due to lack of power.
As a sub-study of the well-designed LIFE-trial (Losartan 
Intervention For End point reduction in hypertension), 
Fossum et al described all-cause mortality and cardiovascular 
end points in a cohort consisting of 9193 patients with hy-
pertension in relation to their physical activity level (never 
exercise, exercise ≤30 minutes twice per week, exercise >30 
minutes twice per week).35,36 The mean follow-up time was 
4.8 years. They found a similar reduction in BP and heart 
rate among the physical activity groups, but only those with 
the highest level of activity had a significant reduction in the 
end points compared with the inactive patients. Because they 
studied a high-risk population with concurrent risk factors, the 
frequency of cardiovascular events was higher than in a ge-
neral population. Despite that, they did not find any significant 
association between moderate activity (exercise ≤30 minutes 
twice per week) and cardiovascular end points. Also, they did 
not consider the level of hypertension in their analyses.
Does the Physical Activity Level Reflect the Health 
Profile?
The level of daily physical activity depends on the person’s 
ability to perform activities. Further, a higher exercise level 
might be a marker of a better health profile. In our study pop-
ulation, we found lower BMI, frequency of diabetes mellitus, 
medication for hypertension, and cardiac medication in the 
highest activity group. The percentage of heavy smokers (>14 
g tobacco/d) was also highest in the inactivity group. Even 
though some of the covariates might have a causal associa-
tion to the level of physical activity (eg, diabetes mellitus and 
BMI), it seems fair to conclude that persons who are in the 
highest activity group might have a better health profile due 
to, for example, better health awareness.
Study Limitations
This study has some limitations. The physical activity level 
was self-reported and not objectively measured. The partici-
pants’ answers might be influenced by their future wishes on 
their exercise level and not reflect the actual level. There might 
also be a probability that they changed their activity level dur-
ing the time between surveys. A previous study from The 
Copenhagen City Heart Study showed that most of the partici-
pants kept their activity level during the repetitive surveys.37
If the persons had an absence from one of the following 
surveys, all the covariates from the previous survey were con-
sidered to be valid until the next time the person took part in 
a survey or until an event or end of follow-up. It would have 
been better if all persons participated in all the subsequent sur-
veys once entered in the study. However, this is not a realistic 
condition to make in a population study. As mentioned above, 
the sensitivity analyses did not show any significant change 
in the results.
The BP was measured as a casual BP measurement, which 
has been validated before and known to be a good predictor of 
outcomes in large epidemiological trials.21,22 We are aware of 
the fact that casual BP is not the best method to diagnose hy-
pertension. Repeated home BP measurement and ambulatory 
BP monitoring are better to detect the presence of hyperten-
sion.28 In a large epidemiological trial such as ours, the best 
method is so far the casual measurement.
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Clinical Impact
Our results justify the importance of regular physical activity 
in the treatment of persons with hypertension and prehyper-
tension. The most important point is that light level of physical 
activity, which almost everyone can perform, is responsible 
for most of the health benefits at all levels of BP, including 
stage 2 hypertension. Doctors and other health professionals 
should encourage patients with hypertension and prehyper-
tension to being physically active at the level of the patient’s 
capability. The recommendation to each patient should be 
individual under consideration of the individual patient’s 
medical history, other risk factors, capability, and ability to 
perform exercise.
Perspectives
Randomized clinical trials are needed to confirm our 
findings. The level of daily physical activity should be 
studied as an intervention in patients with hypertension, 
especially patients with stage 2 hypertension, to deter-
mine the long-term effects of physical activity on prog-
nosis in this patient group. Ongoing medical treatment 
and the interaction with physical activity should be taken 
into consideration.
Conclusions
In conclusion, this study contributes with new knowledge 
on long-term outcomes at all levels of BP. Physical ac-
tivity is associated with lower mortality and cardiovas-
cular events in both hypertension and prehypertension. 
Light level of physical activity is responsible for most of 
the measurable and significant health benefits, and the ben-
efits are even better in higher levels of physical activity. 
The dose-response association between physical activity 
and mortality in hypertension should further encourage 
patients with hypertension to keep their physical activity 
level high. We suggest that all health professionals recom-
mend patients with hypertension to be physically active and 
increase their activity level if it is low.
We suggest, that regular physical activity should be rec-
ommended as a prescribed treatment in all persons with ele-
vated BP.
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What Is New?
•	Higher levels of physical activity are associated with better health ben-
efits in a dose-response pattern at all levels of blood pressure.
What Is Relevant?
•	 Light level of physical activity, which almost everyone can perform, is 
responsible for most of the health benefits at all levels of blood pressure
Summary
In this population-based cohort study comprising 18 974 persons, 
there was a dose-response association between level of daily ac-
tivity and all-cause mortality at all levels of blood pressure: normal 
blood pressure, prehypertension, stage 1 hypertension, stage 2 
hypertension. Compared with inactivity, any level of physical ac-
tivity was associated with a reduction in cardiovascular outcomes 
independent of the blood pressure level. Light-moderate physical 
activity is beneficial in persons with hypertension. Compared with 
inactivity, even a light level of daily physical activity is associated 
with significant health benefits in hypertension.
Novelty and Significance
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Hypertension is a leading risk factor for death globally and is often diagnosed late due to the lack of symptoms be-
fore end organ damage.1,2 Left ventricular hypertrophy (LVH) 
is a well-known complication to hypertension. It is a risk factor 
independent of the level of arterial pressure.3 Its role as an in-
dependent major risk factor for cardiovascular disease and mor-
tality has long been recognized in both electrocardiographic, 
echocardiographic, and cardiac magnetic resonance studies.4–11 
Lowering of the blood pressure (BP) usually leads to regres-
sion of LVH and improved prognosis.12 Diminishing LVH is an 
established goal of treatment in hypertension.13 Beside phar-
macological treatment, nonpharmacological treatment such as 
regular physical activity has shown to reduce LVH in patients 
with hypertension.14–16
Regular physical activity is generally associated with lower 
mortality and cardiovascular events in persons with normal BP 
as well as in persons with hypertension.17–20 However, regular 
physical activity is also associated with physiological cardiac 
adaptations leading to higher left ventricular mass (LVM) 
across the age spectrum.21–24 The increase in LVM induced by 
hypertension is physiologically and histologically different 
from the exercise-induced increase in LVM.25,26 We wanted to 
study if the association between level of physical activity and 
LVM was different in persons with normal BP and in persons 
with hypertension; in other words, if hypertension modified 
the association between level of physical activity and LVM. 
As LVH is associated with worse prognosis, we also wanted 
to study if the benefits of physical activity on prognosis was 
present independent of the presence of LVH.
The 2 aims of this study were therefore to assess:
1. Whether hypertension modifies the association between 
level of physical activity and LVM.
2. Whether LVH modifies the impact of physical activity 
on prognosis
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Abstract—Left ventricular hypertrophy is a strong predictor of prognosis in hypertension. Physical activity is associated 
with higher left ventricular mass but also reduced risk of cardiovascular outcomes. The aims were to explore whether (1) 
presence of hypertension modifies the association between physical activity and left ventricular mass; (2) the beneficial 
association between physical activity and prognostic outcome is modified by left ventricular hypertrophy. Randomly 
selected number of 3078 persons from the general population underwent echocardiogram. Left ventricular mass was 
indexed to body surface area. Level of physical activity was self-reported: inactivity, light activity, and moderate/high 
activity. Blood pressure was measured in rest: normal BP (<140/90 mm Hg) and hypertension (≥140/90 mm Hg or in 
pharmacological treatment for hypertension). Presence of hypertension modified the association between physical 
activity and left ventricular mass index significantly (test for interaction: P=0.01): in normal BP, higher levels of physical 
activity were associated with significantly higher left ventricular mass index (P<0.001), but this was not present in 
hypertension (P=0.90). Level of physical activity was associated with reduction in mortality and cardiovascular outcome 
independent of the presence of LVH (Persons with LVH: light activity HR, 0.77 [0.52–1.15], moderate/high activity 
HR, 0.61 [0.38–0.97]; test for interaction between LVH and level of physical activity P=0.71). In conclusion, persons 
with normal BP had higher left ventricular mass index at increased levels of physical activity, whereas this association 
was not present among persons with hypertension. Level of physical activity was associated with better prognosis 
independent of whether left ventricular hypertrophy was present or not.  (Hypertension. 2020;75:693-701. DOI: 
10.1161/HYPERTENSIONAHA.119.14287.) • Online Data Supplement
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Methods
Data Availability
This study is based on human persons. The Danish Data Protection 
Agency governs the data used in the present study. Any researcher 
who wants to get access to these data must file a formal application 
to the Danish Data Protection Agency. Therefore, the authors cannot 
provide access to the data used in this study.
Population
The description in this paper follows the STROBE guide-
lines (Strengthening the Reporting of Observational studies in 
Epidemiology) for cohort studies.27
The Copenhagen City Heart Study is a longitudinal cardiovascu-
lar cohort study initiated in 1976. Persons of both sexes aged 20 and 
above were randomly selected from the civil register of people living 
in a well-defined area of Copenhagen. The sample was stratified by 
age and sex (5-year age strata from the age of 20 years). The popula-
tion sample went through 4 examinations (1976–78, 1981–83, 1991–
94, 2001–03). All subjects from the original sample were invited to 
all subsequent examinations, and a new random sample of men and 
women was included each time. Echocardiogram was performed in 
the fourth examination (2001–03). The present study is based on data 
from the fourth examination (4th Copenhagen City Heart Study). All 
participants fulfilled a self-administered questionnaire covering ques-
tions on previous medical history, lifestyle, and sociodemographic 
information and underwent a health examination. A total number of 
6237 persons participated in the 4th Copenhagen City Heart Study, 
and a randomly selected number of 3078 persons who underwent 
echocardiogram are included in the current study (Please see online-
only Data Supplement). Whether or not a participant underwent echo-
cardiography was completely independent of his or her health status, 
BP, and other risk factors. All persons gave informed consent to par-
ticipate. The study was undertaken in accordance with the Second 
Helsinki Declaration and approved by the regional ethics committee.
Measurement of BP
BP was measured according to standardized protocols as recom-
mended by Rose and Blackburn.28 The subject was in the sitting posi-
tion, and after 5 minutes of rest, specially trained technicians using a 
London School of Hygiene Sphygmomanometer auscultated BP once 
on the nondominant arm. The mercury column was set to fall by 2 
mm/second. A stethoscope was placed over the brachial artery. The 
first Korotkoff sound indicated systolic BP. The fifth Korotkoff sound 
(when the sounds disappear) signified diastolic BP. Hypertension was 
defined as systolic BP≥140 mmHg or diastolic BP ≥ 90mmHg or if the 
participant was currently treated with antihypertensive medication.29
Level of Daily Physical Activity
Level of daily physical activity was drawn from the self-administered 
questionnaire. A single question with 4 categories was applied for 
measuring leisure time physical activity: Which description most pre-
cisely covers your pattern of physical activity during leisure time?30,31
1. Almost completely passive or physically active for <2 hours/
week (eg, reading, watching television, going to cinema, en-
gaging in light physical activity such as walking or cycling; 
intensity: <3 metabolic equivalents)
2. Light physical activity 2 to 4 hours per week (eg, walking, cy-
cling, light garden work, or low-intensity workouts; intensity: 
3.0–4.5 metabolic equivalents)
3. Engaging in light physical activity for >4 hours per week or more 
vigorous activity 2 to 4 hours per week (eg, brisk walking, fast 
cycling, heavy gardening, physical activities that cause perspira-
tion or exhaustion; intensity: 4.5–6.0 metabolic equivalents)
4. More strenuous physical activity for >4 hours per week or regu-
lar heavy exercise or competitive sports several times per week 
(intensity: >6.0 metabolic equivalents)
Because of few persons in category 4 (n=297), persons who answered 
3 or 4 were included in the same category. The variable was hereby 
categorized into: inactivity, light activity, or moderate/high activity.
Echocardiogram
Three echo technicians using GE Vingmed Ultrasound’s Vivid Five 
with 2.5 MHz probe (Horten, Norway) performed all echocardio-
grams. All images were recorded using second harmonic imaging 
at the time of end-expiration. All echocardiograms were stored on 
magneto-optical disks and an external FireWire hard drive (LaCie, 
France) and analyzed offline with commercially available software 
(EchoPac, GE Medical, Horten, Norway) by investigators who were 
blinded to all other information about the participants. Further details 
on the echocardiograms in The Copenhagen City Heart Study have 
been published previously.32–34
Analysis of Echocardiogram
The following measures were quantified in end diastole: posterior 
wall thickness, left ventricular end diastolic diameter, septal wall 
thickness. LVM was calculated using Devereux formula.35,36 Left 
ventricular mass index (LVMi) was calculated as the anatomic mass 
divided by the body surface area.35,37,38 LVH was defined as LVMi 
>115 g/m2 for men and >95 g/m2 for women according to current 
guidelines.36 Concentric LVH was defined as presence of LVH and 
relative wall thickness >0.42. Eccentric LVH was presence of LVH 
and relative wall thickness <0.42. Relative wall thickness was cal-
culated using the formula: relative wall thickness=2× posterior wall 
thickness/left ventricular end diastolic diameter.36
Follow-Up and Outcome
All participants were enrolled from 2001 to 2003 and followed until death 
or 13 December 2018. Danish citizens have a unique civil registration 
number, which is linked to the Danish Civil Registration System, Danish 
National Patient Register, and Danish Register of Causes of Death.39–41 
From these registers, information on hospital admissions, death date, 
and cause of death was obtained. None of the participants was lost to 
follow-up. During follow-up, 1.3 % of the study population (n=40) emi-
grated from Denmark, and they were followed in the registries until the 
date of emigration. The primary outcome was all-cause mortality. The 
secondary outcome was cardiovascular events defined as hospital admis-
sion or death due to acute myocardial infarction, heart failure, or stroke.
Statistics
For demographics, comparisons between groups were performed 
by Pearson χ2 test for categorical variables and 1-way ANOVA for 
continuous covariates. Linear regression models were used to assess 
the association between physical activity and LVMi and whether hy-
pertension modified this association. Means and CIs in each of the 
activity groups were estimated in the multivariable linear regression 
analysis. Activity level was considered as a categorical variable. 
Linearity, variance of homogeneity, and the assumption of normality 
were tested with plots of residuals. Likelihood ratio test was per-
formed when testing for interaction and trend.
Time to Event Analyses
Cox proportional hazards regression models were used to assess the 
association between LVMi, cardiovascular events, and all-cause mor-
tality. The underlying time scale was follow-up time since health 
examination. Subjects were followed until death or, if still alive 
December 13, 2018. For cardiovascular events, subjects were fol-
lowed until their first cardiovascular event (admission or death due 
to acute myocardial infarction, heart failure, or stroke). Death from 
other causes was considered as a competing risk. A Fine and Gray 
subdistribution hazards model with death from other causes as a com-
peting risk was performed. Interaction analyses were performed to 
explore whether LVH modified the association between physical ac-
tivity and the defined outcomes.
The P values for the differences between the cumulative inci-
dence curves were assessed by log-rank test (all-cause mortality) and 
Fine and Gray analysis (cardiovascular events).
In all multivariable analyses, the following covariates were consid-
ered as confounders: sex, age, previous cardiovascular disease, smok-
ing status (never smoker, former smoker, current smoker), diabetes 
mellitus, and total cholesterol. Additional adjustment for hypertension 
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was made when the study population was not stratified on normal BP 
versus hypertension. Body mass index was not included as a confound-
er because body size was included in the calculation of LVMi and LVH.
Two-sided P values <0.05 were considered statistically signifi-
cant. Values in parentheses are 95% CIs unless stated otherwise.
Stata Statistics/Data Analyses version 15.1 was used for all 
analyses.
Sensitivity Analysis
Thyroid status is associated with alterations in cardiac morphology in-
cluding LVMi.42,43 Diet might also affect LVMi.44,45 Therefore, we made 
sensitivity analyses with additional adjustment for both thyroid status 
and diet (low fat intake, medium fat intake, high fat intake). Definition 
of thyroid status: euthyroid (thyrotropin/TSH ≥0.3 and ≤4.0 μIU/L), 
hyperthyroid (TSH<0.3 μIU/L), hypothyroid (TSH>4.0 μIU/L).
Results
Population Characteristics
Persons with normal BP were younger and had better health status 
than the group with hypertension: lower body mass index, lower 
frequency of diabetes mellitus, previous cardiovascular disease, 
and smoking (Table). In both groups, higher activity levels were 
associated with better health profile. In both BP groups, we found 
lower resting heart rate and lower body mass index among the 
activity groups. Left ventricular diastolic function assessed by è 
was reduced in persons with hypertension and was better in higher 
activity levels among persons with normal BP. LVH was more fre-
quent in persons with hypertension, and among them, concentric 
LVH was the predominant LVH type in the inactivity group.
Outcome and Follow-Up
During a mean follow-up of 12.5±5.4 years, 941 deaths 
occurred, and the majority were identified among persons 
with hypertension (N=687 [73%]). In total, 894 cardiovas-
cular events occurred (214 cardiovascular deaths; 680 admis-
sions due to stroke/heart failure/acute myocardial infarction). 
Most of the events (N=613 [69%]) occurred among persons 
with hypertension at baseline.
Table. Population Characteristics
Characteristic
Total 
Normal BP 
(N=1702)
Normal BP
Total 
Hypertension 
(N=1376)
Hypertension
P Value for 
Comparison 
Between the 
2 BP Groups
Inactivity 
(N=109)
Light 
Activity 
(N=764)
Moderate/
High 
Activity 
(N=829) P Value
Inactivity 
(N=129)
Light 
Activity 
(N=762)
Moderate/
High 
Activity 
(N=485) P Value
Age, y 49±15 48±16 52±15 47±15 <0.001 67±12 68±13 68±12 64±12 <0.001 <0.001
Male sex, no., % 719 (42) 48 (44) 289 (38) 382 (46) 0.004 551 (40) 58 (45) 262 (34) 231 (48) <0.001 0.22
Systolic BP, mm Hg 120±11 118±12 120±11 119±11 0.01 154±18 153±18 155±18 154±17 0.78 <0.001
Diastolic BP, mm Hg 72±9 72±10 73±9 72±9 0.22 85±12 83±13 84±12 86±12 <0.01 <0.001
BMI, kg/m2 24.5±3.5 25.3±3.9 24.7±3.7 24.1±3.2 <0.001 26.6±4.3 27.8±5.1 26.6±4.3 26.2±3.9 <0.001 <0.001
RHR/bpm 65±10 69±11 66±10 64±11 <0.001 69±12 72±12 70±13 67±12 <0.001 <0.001
Diabetes mellitus, no., % 27 (2) 2 (2) 9 (1) 16 (2) 0.47 113 (8) 19 (15) 64 (8) 30 (6) 0.007 <0.001
Previous CVD, no., % 86 (5) 7 (6) 46 (6) 33 (4) 0.14 234 (17) 38 (29) 140 (18) 56 (12) <0.001 <0.001
Smoking, no., %
  Never 587 (35) 31 (28) 230 (31) 326 (40)  434 (32) 27 (22) 245 (33) 162 (34)   
  Former 510 (31) 23 (21) 244 (33) 243 (30) <0.001 499 (37) 38 (31) 269 (36) 192 (40) <0.001 0.001
  Current 570 (34) 55 (50) 271 (36) 244 (30)  417 (31) 59 (48) 233 (31) 125 (26)   
LVEF<50%, no., % 12 (0.7) 1 (1) 6 (0.8) 5 (0.6) 0.88 20 (1.5) 1 (0.8) 13 (2) 6 (1) 0.62 0.04
Cholesterol, mmol/L 5.2±1.1 5.3±1.2 5.3±1.1 5.1±1.1 <0.001 5.7±1.2 5.7±1.2 5.7±1.2 5.7±1.2 0.93 <0.001
Thyroid status, no., %
  Euthyroid 1578 (94) 105 (96) 698 (93) 775 (93)  1228 (91) 108 (87) 666 (89) 454 (95)   
  Hyperthyroid 22 (1) 1 (1) 11 (1) 10 (1) 0.56 31 (2) 4 (3) 21 (3) 6 (1) 0.01 0.001
  Hypothyroid 73 (4) 3 (3) 39 (5) 31 (4)  92 (7) 12 (10) 60 (8) 20 (4)   
LVMi, g/m2 80±19 77±17 79±20 82±19 <0.001 94±25 96±24 94±25 94±24 0.69 <0.001
è 8.6±2.6 8.4±2.7 8.3±2.4 8.9±2.6 <0.001 5.7±1.9 5.7±2.0 5.6±1.9 5.9±2.1 0.19 <0.001
LVH, no., % 144 (8) 4 (4) 61(8) 79 (10) 0.10 405 (29) 45 (35) 231 (30) 129 (27) 0.14 <0.001
Type of LVH, no., %
  Eccentric LVH 97 (67) 3 (75) 42 (69) 52 (66)  225 (59) 20 (44) 126 (55) 79 (61)   
  Concentric LVH 47 (33) 1(25) 19 (31) 27 (34) 0.9 180 (44) 25 (56) 105 (45) 50 (39) 0.13 0.01
The participants are grouped according to their BP level (normal BP/ hypertension) and their level of physical activity. BMI indicates body mass index; BP, 
blood pressure; CVD, cardiovascular disease; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; LVMi, left ventricular mass index; and RHR, 
resting heart rate.
D
ow
nloaded from
 http://ahajournals.org by on July 15, 2020
696  Hypertension  March 2020
Physical Activity and LVMi
At baseline, the mean LVMi in the hypertensive group 
(n=1376) was significantly higher as compared with the 
nonhypertensive group (n=1702; 94±25 versus 80±19 g/m2; 
P<0001). Presence of hypertension modified the association 
between physical activity and LVMi (test for interaction: 
P=0.01). In persons with normal BP, higher levels of phys-
ical activity were associated with significantly higher LVMi 
(P<0.001), whereas in persons with hypertension, there was 
no significant association between physical activity and 
LVMi (P=0.97). Figure 1 illustrates the adjusted means of 
LVMi according to level of physical activity in persons with 
hypertension and in persons with normal BP, respectively, 
after adjustment for age, sex, previous cardiovascular di-
sease, smoking status, diabetes mellitus, and total choles-
terol. Additional adjustment for thyroid status and diet did 
not change the result pattern.
Impact of LVH and Physical Activity on Outcome
Physical activity was associated reduction in mortality and 
cardiovascular events (for persons with LVH: inactivity (ref-
erence); light activity HR, 0.77 [0.52–1.15]; moderate/high 
activity HR, 0.61 [0.38–0.97] for all-cause mortality). This 
association was not modified by LVH (test for interaction: 
P=0.71; Figures 2 and 3). Additional adjustment for thyroid 
status and diet did not change the impact of physical activity 
on outcome (cardiovascular events for persons with LVH: in-
activity [reference]; light activity HR, 0.76 [0.51–1.15]; mod-
erate/high activity HR, 0.65 [0.41–1.04]).
The Prognostic Importance of LVH
Presence of hypertension did not modify the association 
between LVH and prognosis (Figure 4). The prognostic im-
portance of LVH did not differ between the activity levels 
(Figure 5).
Persons in Medical Treatment for Hypertension
A subgroup analysis only including persons who received 
antihypertensive medication at baseline showed the same pat-
tern of results: level of physical activity was not associated 
with LVMi (P=0.97). Level of physical activity was associ-
ated with a corresponding reduction in outcome independent 
of the presence of LVH (test for interaction: P=0.78).
Discussion
This study had 3 main findings: first, LVMi was significantly 
higher at increased levels of physical activity among per-
sons with normal BP, whereas this association was not found 
among persons with hypertension. Second, physical activity 
was associated with better prognosis despite the presence of 
LVH. This means that being physically active with hyper-
tension was not associated with further increase in LVM. 
Furthermore, being physically active even in the presence of 
hypertension and LVH was associated with better prognosis 
compared with inactivity.
LV Mass, LVH, and Physical Activity in 
Hypertension
LVH induced by hypertension is known as a pathological hy-
pertrophy and is a result of increased systemic pressure and 
volume overload leading to increased workload on the left 
ventricle.25 Physiological hypertrophy refers to the cardiac 
adaptation of the left ventricle due to high workload, for ex-
ample, pregnancy and physical activity. Physiological hy-
pertrophy regresses quickly when training is discontinued,46 
while regression of hypertension induced LVH might occur 
slowly after normalization of BP.12
Cardiovascular events including sudden cardiac death are 
more frequent in patients with LVH.3
As physical activity is associated with a further ele-
vation in BP and afterload during exercise, it could be a 
concern if the combination of hypertension, LVH, and mod-
erate/high level of physical activity might be harmful. Our 
study does not imply any harmful associations with prog-
nosis when persons with both hypertension and LVH have 
increased activity levels.
Although we did not find a significant change in LVMi 
in higher activity levels among persons with hypertension, 
previous studies found that physical activity in persons with 
hypertension was associated with decrease in LVM.14,15,47–49 
The reason we did not find any association between LVMi 
and level of physical activity could be due to lack of power. 
Besides, factors like duration of hypertension and duration of 
the reported level of physical activity might also play a role.
The benefits of physical activity on hypertension and LVH 
was already described in 1995 by Kokkinos et al48 who per-
formed a well-designed randomized intervention trial show-
ing how regular exercise reduced both BP and LVH in black 
men with severe hypertension, who were already treated with 
antihypertensive medication.
The impact of physical activity on LVM was later con-
firmed in 2009 by Palatini et al50 studying 454 Italian habi-
tants with hypertension in a prospective longitudinal study 
design. None of them had LVH at baseline and the echo-
cardiograms were repeated during the follow-up of 8 years. 
Figure 1. Left ventricular mass and physical activity. Adjusted means 
of left ventricular mass index (LVMi) according to the activity levels and 
blood pressure (BP) groups after adjustment for age, sex, previous 
cardiovascular disease, smoking status, diabetes mellitus, and total 
cholesterol. *P values for trend test for the association between LVMi and 
level of physical activity in each of the BP groups after adjustment for 
confounders.
D
ow
nloaded from
 http://ahajournals.org by on July 15, 2020
Joseph et al  Exercise, Left Ventricular Mass, and Hypertension  697
The activity level was self-reported and categorized into 
Sedentary or Active. They concluded that performing reg-
ular physical activity was associated with a lower risk of 
LVH. The impact of physical activity on the development of 
LVH was independent of changes in BP and body weight. In 
2011, Pitsavos et al published a study including 52 men with 
mild hypertension and without previous cardiovascular di-
sease. Half of the study population was assigned to 16 weeks 
training programme, and the other group was allocated to 
a nonexercise arm.51 They found a significant reduction in 
Figure 2. Left ventricular hypertrophy (LVH), 
physical activity, and outcome. Cumulative 
incidence of all-cause mortality (top) and 
cardiovascular events (bottom) according to 
the activity levels. Stratified on the presence 
of LVH. Cardiovascular events defined as 
admissions or death due to heart failure, stroke, 
or acute myocardial infarction.
Figure 3. Left ventricular hypertrophy (LVH), 
physical activity, and outcome. Forest plot. 
Top, all-cause mortality (left) and cardiovascular 
events (right) according to the level of physical 
activity for persons without LVH. Bottom, all-
cause mortality (left) and cardiovascular events 
(right) according to the level of physical activity 
for persons with LVH. Multivariable analyses. 
Adjusted for age, sex, diabetes mellitus, total 
cholesterol, previous cardiovascular disease, 
smoking status, and hypertension. Test for 
interaction between LVH and level of physical 
activity for all-cause mortality: P=0.95. Test for 
interaction between LVH and level of physical 
activity for cardiovascular events: P=0.97. 
*P<0.05; **P<0.01; ***P<0.001.
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resting and exercise BP levels, lower RHR, and lower LVM 
in the training group. However, in both studies, only persons 
without LVH on echocardiography were included. Thus, 
conclusions cannot be drawn for a high-risk hypertensive 
population who already has LVH at baseline.
The impact of physical activity on the prognosis in a high-
risk population with both hypertension and LVH was explored 
in the interesting study performed by Fossum et al52 as part 
of the well-conducted LIFE-trial (Losartan Intervention for 
End point Reduction in Hypertension). The level of physical 
activity was self-reported and categorized into never exer-
cise, ≤30 minutes twice per week, and ≥30 minutes twice per 
week. After a mean follow-up of 4.8 years, they found that 
both physical activity levels were associated with reduction in 
several cardiovascular end points and all-cause mortality. The 
findings were mostly significant for the modest activity level 
(≥30 minutes twice per week). Thus, our study supports their 
findings, as both studies explored the association between 
self-reported activity level and outcome in person with both 
hypertension and LVH.
In our study, we found that persons already in med-
ical treatment did not have higher LVMi with increased 
activity levels. This finding is supported by Ketelhut et 
al53 in a study investigating changes in LVM in medically 
treated athletes with hypertension. They were compared 
with hypertensive sedentary controls treated with medica-
tion. The results showed that LVM at baseline was higher 
in hypertensive athletes compared with the controls. The 
athletes continued performing regular aerobic training dur-
ing follow-up. LVM decreased in both groups after end of 
follow-up. They explained this finding as the effect of anti-
hypertensive medication. However, in athletes with hyper-
tension, physical activity might also induce regression of 
pathological hypertrophy.
Impact of Physical Activity and LVH on Prognosis
The reason why we should draw attention to the association 
between level of physical activity and LVH in hypertension 
is, that several previous studies have shown that regression 
of LVH is associated with reduction in cardiovascular mor-
bidity and mortality.12,54,55 In these studies, regression of 
LVH was achieved by pharmacological treatment. However, 
more studies are needed on the association between level of 
physical activity, change in LVM and its impact on long-
term prognosis.
Increased level of physical activity was associated with 
reduced outcome independent of the presence of LVH. This 
underscores the importance of physical activity in determining 
the prognosis as concluded in other studies.18,20
Persons already receiving optimal medical treatment 
might be in another risk category than persons with newly 
diagnosed hypertension. Physical activity might thus have 
a different impact on their LVM as well as their prognosis. 
The echocardiographic parameters including LVMi might 
also be affected by the treatment. The subgroup analyses 
we conducted in this study did not imply that this group 
differed from the rest of the persons with hypertension re-
garding neither the association between level of physical 
activity and LVMi, nor the impact of LVH and physical ac-
tivity on the prognosis.
Figure 4. Blood pressure (BP) level, left 
ventricular hypertrophy (LVH), and outcome. 
Forest plot. All-cause mortality (left) and 
cardiovascular events (right) according 
to the BP group and presence of LVH. 
Multivariable analyses. Adjusted for age, sex, 
diabetes mellitus, total cholesterol, previous 
cardiovascular disease, smoking status, and 
level of physical activity. Test for interaction 
between LVH and hypertension for all-cause 
mortality: P=0.16. Test for interaction between 
LVH and hypertension for cardiovascular 
events: P=0.16. *P<0.05; ***P<0.001.
Figure 5. Physical activity level, left 
ventricular hypertrophy (LVH), and outcome. 
Forest plot. All-cause mortality (left) and 
cardiovascular events (right) according to 
the level of physical activity and presence 
of LVH. Multivariable analyses. Adjusted for 
age, sex, diabetes mellitus, total cholesterol, 
previous cardiovascular disease, smoking 
status, and hypertension. Test for interaction 
between level of physical activity and LVH for 
all-cause mortality: P=0.95. Test for interaction 
between level of physical activity and LVH 
for cardiovascular events: P=0.97. *P<0.05; 
**P<0.01; ***P<0.001.
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Strengths and Limitations
The large number of persons included in the study and the 
long follow-up time without any missing participants at the 
end of follow-up are valuable qualities of this study. The stan-
dardized BP measurement (casual BP) has also been validated 
in previous epidemiological trials.56,57 One of the limitations is 
that level of physical activity is self-reported and does not nec-
essarily represent the actual activity level for each of the indi-
viduals. Further, we do not know if the participants changed 
their level of physical activity during the follow-up.
Another limitation is that we do not have information on 
the type of medication prescribed to the persons already in 
pharmacological treatment at baseline. Neither do we have 
information on initiation of antihypertensive drugs during 
follow-up in persons categorized in the hypertensive group 
at baseline. Beyond the effects of BP reduction, some of the 
drugs, especially blockers of renin-angiotensin-aldosterone 
system, have favorable effect on regression of LVH, and might 
interfere with the prognosis associated with LVH.58–60
Clinical Implication
This study shows that higher levels of physical activity is 
not associated with further increase in LVM in persons with 
hypertension. A patient with hypertension and LVH should 
without concerns be encouraged to increase the level of ac-
tivity due to the patient’s clinical condition and capability.
Conclusions
Increased level of physical activity was associated with higher 
LVMi in persons with normal BP. This association was not pre-
sent among persons with hypertension. Compared with inactivity, 
higher levels of activity were associated with better prognosis, 
and this association was independent of the presence of LVH.
Perspectives
Further studies are needed to confirm that physical activity is 
not harmful in persons with both hypertension and LVH, and 
that physical activity might rather induce beneficial alterations 
in left ventricular morphology. Randomized trials including 
specific training programmes for hypertensive subjects with 
and without LVH, respectively, might provide more know-
ledge about changes in cardiac morphology and long-term 
prognosis in this patient group. Interaction between the effects 
of medical treatment and physical activity also needs to be 
explored in future studies. However, it is notable that we now 
have more studies indicating that physical activity is bene-
ficial for persons with hypertension, including patients with 
LVH, who comprise a high-risk population.
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What Is New?
•	 Increased levels of physical activity are associated with higher left ven-
tricular mass in persons with normal blood pressure, and this association 
is not present in persons with hypertension. The health benefits of phys-
ical activity on prognosis is present in both persons with left ventricular 
hypertrophy and in persons without left ventricular hypertrophy.
What Is Relevant?
•	 It is not harmful to perform physical activity in the presence of both hy-
pertension and left ventricular hypertrophy.
Summary
In this population-based cohort study comprising 3078 persons, 
higher levels of physical activity were associated with increased 
left ventricular mass in persons with normal blood pressure, 
whereas this association was not present in persons with hyper-
tension. Compared with inactivity, higher levels of physical activity 
were associated with corresponding reduction in mortality and car-
diovascular outcome. This association was present independent of 
whether left ventricular hypertrophy was present or not.
Novelty and Significance
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